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For the potential benefit of progenitor cells to be realized in cell-based clinical therapies, it is 
vital to investigate the mechanism between progenitor cells and abnormal tissue formation.  
Laminitis is a fatal condition that is often presented by equine hoof inflammation and hoof 
tissue disarrangement. The persistence of abnormal tissue formation after the resolution of 
equine laminitis suggests there is progenitor cell compromise. So far, there is limited 
information about equine hoof progenitor cells and the effects of inflammation on hoof 
progenitor cells. To pursue a better understanding of both hoof progenitor cell and hoof 
growth as well as find potential progenitor cell-based treatments for hoof injuries, we choose 
hoof progenitor cells to create an in vitro model to study hoof cell characteristics. Primary 
progenitor cells were isolated from fresh equine laminae as well as cryopreserved laminar 
tissue and characterized in vitro. Results indicate hoof progenitor cells from fresh tissue have 
multilineage differentiation capacity and show similar cell doublings, CFU frequencies, 
surface antigen, and gene expressions when compared to other reported stem cells. The 
majority of hoof progenitor cell isolates are K14+CD105+ population that may result from 
the specific dermal-epidermal hoof structure. K14+CD105+ progenitor cells, progenitor cells 
from unaffected, laminitic and cryopreserved laminar tissue show different cell behaviors on 
decellularized laminar scaffolds and distinct ultrastructural morphology. This indicating hoof 
progenitor cells have variable metabolic and synthetic capabilities determined by different 
preharvest tissue conditions and postharvest conditions. K14+CD105+ progenitor cells have 
a stronger proliferation rate and higher epithelial to mesenchymal transition (EMT) marker 
expression compared to heterogeneous cell isolates. This suggests that cell plasticity required 
to maintain both the interface and two tissue types may be enhanced by EMT capabilities. 
Cells loss epithelial characteristics by culturing with inflammatory cytokines while normal 
matrix may promote epidermal gene expression. EMT protein expression was increased by 
 
                                                                                   x 
                                                                                    
 
 
culturing with medium containing inflammatory cytokines, which indicating inflammatory 
cytokines may support a propensity for EMT. Overall, outcomes in this dissertation provide 
invaluable information for a better understanding of hoof cell composition and hoof disease 
prevention. Likewise, the work informs future progenitor cell-based dermal-epidermal tissue 
engineering. 
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CHAPTER 1. THE EQUINE HOOF: INFLAMMATION AND 
PROGENITOR CELLS 
 
1.1. Equine hoof laminitis and progenitor cells: history and current situation 
Aristotle described the relationship between laminitis, inflammation of the equine hoof, and 
overfeeding of barley around 350 BC. [1] The condition is commonly called “founder”. 
Currently, the incidence of laminitis is approximately 34%, with an estimated lifetime risk of 
15% in north America. [2, 3] There are descriptions of laminitis, defined as inflammation of 
sensitive hoof tissues but recognized as pathologic changes with or without inflammatory 
mediators, or from endocrine and metabolic diseases, in the earliest records of domesticated 
horses. Despite decades of research focused on this devastating disorder, there has been 
relatively little progress to prevent or treat it. Decades of research contribute to contemporary 
standards of care that include systemic and local therapies as well as mechanical hoof support. 
[4, 5] Descriptions of hoof wall inflammation, laminitis, exist in some of the earliest records 
of domesticated horses. Laminitis severity can range from mild to serious, and signs can be 
acute, chronic, or transition from acute, severe inflammation to permanently weakened, 
disordered tissue. Regardless of the duration of laminitis, tissue damage tends to occur within 
the intricate dermal and epidermal hoof connections on the primary and secondary lamellae. 
Disruption of tissue integrity is associated with lifelong changes to hoof growth, repair, and 
conformation. Current clinical and laboratory research contribute to the understanding of cell 
signaling pathways that include epithelial to mesenchymal transition pathways. Despite this, 
consistent mechanisms to restore healthy tissue formation following an inflammatory insult 
are lacking. The ability of endogenous and exogenous progenitor cells to contribute to and 
direct healthy tissue formation is established for most tissues. Relatively little information is 
currently available, however, about equine hoof progenitor cells. Equine hoof anatomy, tissue 
inflammation, and progenitor cells are covered in this review. The potential of progenitor 
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cells to advance in vitro equine hoof tissue models and translate to clinical therapies may 
significantly advance prevention and treatment of a devastating condition that has afflicted 
equine companions throughout history.  
1.2. Equine hoof structure, growth and keratins 
The equine hoof capsule, composed of modified epidermis and dermis, is vital for protecting 
the third phalanx while propagating forces of locomotion from the ground to the limb. Hoof 
wall has three layers including stratum externum (tectorium), medium, and internum 
(lamellatum). The stratum externum is composed of cornified tissue formed by germinal cells 
in the perioplic corium located superficial to the coronary corium that produces the stratum 
medium. [6] The thickest stratum medium layer is consist of both pigmented intertubular and 
tubular horn. [7] As new cells are formed in the coronary band; the existing cells are pushed 
distally and eventually cornify. [8] 
Stratum internum is composed of epidermal and dermal lamellae, that are continuous with the 
tubular horns of the stratum medium and the periosteum of the distal phalanx, respectively 
(Fig. 1). The suspensory apparatus of the distal phalanx is a network of collagen bundles that 
connects the distal phalanx to the stratum internum and permits the hoof wall to act as a 
principal weightbearing structure. [9] Collagen bundles extend from the distal phalanx and 
insert on the laminar basement membrane between the secondary dermal and epidermal 
laminae. [10] The lamellae epidermis is non-sensitive and avascular, but dermis has blood 
vessels and in a dense matrix of tough connective tissue. [11] Both primary epidermal and 
dermal laminae are frond-like shapes that have smaller frond-like structures, secondary 
laminae, on their surface. The junction between the epidermal and dermal components of the 
lamellae is a complex basement membrane to which epithelial basal cells are attached via 
hemidesmosomes or electron dense adhesion plaques and the dermis is connected via 
insertion and anchoring fibrils composed of proteins like collagen and laminin. [12, 13] The 
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highly complex morphology of the primary and secondary laminae can vary regionally, likely 
due to different functions. [14] 
 
Figure 1. Illustration of the internal components of the equine hoof in images with no (b) to 
progressively higher (c, 10x; d, 20x) magnification. The perioplic corium (b, PC) and 
coronary corium (b, CC) are shown in addition to the primary epidermal (c, PEL, black arrow) 
and dermal (c, PDL) lamellae and the secondary epidermal (d, SEL) and dermal (d, SDL) 
lamellae. P3 = Third phalanx. 
 
Keratins are the major structural proteins, largest subgroup of intermediate filament proteins, 
and vital cell signaling participants in epithelial cells. They are non-soluble proteins with 
distinct physicochemical properties, intermediate structures, and mechanical behaviors that 
broadly divide them into soft or hard keratins and contribute to the variable properties of 
different hoof regions. [15-17] Disulfide bonds within keratin filaments convey strength and 
hardness proportionate to the number of bonds present, and hard keratins tend to have more 
than soft. [18] Amino acid sequences determine the secondary, tertiary and quaternary 
structures of keratins. [19] They are often combined with other proteins like keratin filament-
associated proteins and mineral binding enzymes and can vary from fibrous to amorphous. 
[20, 21] In the epidermis, keratins produced by keratinocytes exist as keratohyaline granules 
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within the cells. [22] Keratin 14 is a cytokeratin typically found in the cytoskeleton of 
epidermal cells that is expressed by basal cells between the secondary epidermal and dermal 
lamellae (Fig. 2). As the names imply, soft keratins are typically the largest component of 
relatively soft cornified epithelia, while hard keratins are the major population in hard 
cornified tissue like the hoof wall.  
The type and number of keratins within a tissue tend to change with age and pathology. [23, 
24] Accordingly, there are distinct differences in keratins within the stratum lamellatum of 
unaffected versus inflamed hooves. In endocrinopathic laminitis, laminar tissue is partially 
replaced with aberrant keratin, and keratinization of primary epidermal lamellae is markedly 
increased compared to normal. In addition, keratinocyte hyperproliferation is documented in 
hooves affected by insulin-induced laminitis. [25, 26] Abundant keratohyalin in the normal 
hoof stratum externum and cytokeratins in epidermal basal cells are not evident in inflamed 
hoof tissue. [27] Cytokeratin 14 clusters around the nucleus in hooves with carbohydrate 
overload induced laminitis compared to the normal cytoplasmic location. [28] Based on this 
information, changes in keratin content and location provide a unique mechanism to 
determine cell phenotype, maturity level, and pathology within equine hoof tissue.  
 
Figure 2. Fluorescent photomicrographs showing fluorescent labeling of keratin 14 (arrow, 
green), in basal cells between secondary epidermal (SEL) and dermal (SDL) lamellae within 
the stratum internum of equine hoof tissue. Nuclei are stained blue. 
 
The hoof wall of a normal adult horse grows at a rate of approximately 0.24-0.4 inches (6-10 
millimeters) per month. [29] Stratum medium growth occurs by division of epidermal basal 
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cells on papillae within the coronary corium. [9] As the basal cells (Fig. 3) divide, they drive 
older cells toward the ground surface to create the tubular and intertubular horns of the hoof 
wall. [6] There are several reports surrounding tissue growth in the stratum internum that is 
thought to occur, in part, by proliferation of basal cells on the proximal lamellae. Theories 
exist about the process by which the strong attachment with the stratum medium is 
maintained while it grows downward. [8] It is generally agreed that tissue homeostasis 
includes balanced synthesis and enzymatic degradation of extracellular matrix by resident 
cells. Proteins like tissue inhibitors of metalloproteinases (MMPs) are crucial to the process. 
[30] Disruption of tissue homeostasis by upregulation of neutrophil MMP (e.g., MMP2 and 
MMP9) production of proinflammatory cytokines such as interleukin (IL) 1β and 8 are 
thought to contribute to destruction of the epidermal-dermal interface in inflamed tissue. [31, 
32] Within the basement membrane, laminin stabilization of the epidermal-dermal tissue 
attachment is targeted by MMPs during laminitis. [33] While it is clear that coordination of 
tissue production and degradation is disrupted by inflammatory mediators, the exact 
contributions of and consequences to resident progenitor cells have yet to be determined. [34] 
 
Figure 3. Transmission electrophotomicrograph of a desmosome like structure (arrow) 




1.3. Inflammatory mediators and inducible laminitis models 
There are four recognized stages of laminitis, developmental, acute, subacute and chronic. 
[35]  The developmental phase occurs between the first insult and the appearance of initial 
clinical signs. The acute phase is from first clinical signs to displacement of the third phalanx, 
thought to result from a combination of tension from the deep digital flexor tendon, weight 
bearing forces, and breakdown of the dermal-epidermal junction. Subacute condition is 
classified as no displacement of third phalanx within 72 hours. Subsequent laminar tissue 
failure with progressive third phalanx displacement is regarded as chronic laminitis (Fig. 4). 
[35, 36] 
Laminar tissue inflammation can occur secondary to any number of systemic or local insults. 
Inflammatory mediators, circulatory compromise, and compression injury may all contribute 
to tissue damage. [37, 38] Predisposing conditions for laminitis are numerous, range from 
equine metabolic syndrome to pituitary pars intermedia dysfunction, and most are associated 
with some level of systemic inflammation mediated by cytokines and hormone imbalance. 
[39] Obesity is thought to increase predisposition to laminitis by disrupting hoof homeostasis, 
in part, by adipose tissue production of inflammatory cytokines like tumor necrosis factor 
(TNF)-α, IL-6, and IL-1β, all of which decrease insulin receptor signaling and insulin 
sensitivity. [40] Obesity is also associated with elevated cortisol levels from overexpression 
of 11β-hydroxysteroid dehydrogenase-1 in human patients and horses with insulin resistance, 
type 2 diabetes, and hyperlipidemia. [41] Besides the inciting cause, hoof inflammation can 
seriously damage the crucial epidermal-dermal bond that maintains structural integrity of the 
hoof soft tissues. Potentially due to differences in the root cause of the inflammation as well 
as individual characteristics, disease severity and progression vary widely.  
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Figure 4. Radiographs of an unaffected (A) and laminitic hoof (B). The third phalanx (P3) is 
rotated and displaced distally in the radiograph of the hoof with laminitis.  
 
To study the chronology and pathophysiology of hoof inflammation, toxicants and high doses 
of naturally occurring proteins have been used historically to repeatably induce the condition 
in horses for sequential evaluations from the onset. Pathologic changes vary with toxin and 
dose. [42-44]  Use of endotoxin to cause laminitis was abandoned since it created systemic 
and local signs of laminitis, but it did not cause tissue changes characteristic of the condition. 
[45, 46] Carbohydrate overload (CHO) with corn starch and wood cellulose flour or black 
walnut extract (BWE) cause microstructural changes in the hoof that resemble those of 
naturally occurring laminitis. [42, 47] Oligofructose derived from chicory root and 
hyperinsulinemia are also used to create inflammatory conditions in the hoof. [43, 48] Years 
of research have resulted in a diverse set of mechanisms to induce hoof inflammation for 
purposes of study. 
As previously indicated, the lamellae appear to be the most vulnerable to the consequences of 
laminitis. Given the role of resident cells to tissue homeostasis and repair, careful 
consideration of changes in both cells and tissue is necessary to compare the models of acute 
laminitis to the naturally occurring condition (Table 1). In models and naturally occurring 
laminitis (Fig. 5), innate and adaptive immune cells accumulate around microvasculature and 
the stratum lamellatum epidermal-dermal interface (Table 1). [49, 50] Calprotectin, an 
inflammatory protein, is expressed by extravasated white blood cells on the epidermal side of 
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the basement membrane in natural and induced laminitis. [51, 52] Microstructural damage 
and cell loss on and around the basement membrane is comparable among models and 
laminitis; however, changes in naturally occurring laminitis can be subtler than 
experimentally induced laminitis. Basal cell cytoskeleton collapse is associated with glucose 
deprivation and metalloproteinase activation in the oligofructose model. [32] 
Hemidesmosomes between basal cells are lost in the oligofructose, CHO, and insulin models. 
[53-55] In the CHO model, there is basement membrane necrosis and loss of epithelial cells 
between the secondary epidermal and dermal lamellae. [56] With high-dose insulin, laminar 
epithelial cells are abnormally elongated and subject to dyskeratosis and apoptosis. [25, 57] 
Gene and protein expression between natural and induced laminitis are somewhat comparable. 
In natural laminitis, p63, a regulator of epidermal stem cells decreases, while proteins 
involved with vascular inflammatory reactions like gamma-histoneH2A and endothelin-1 
expression increase. [26, 58, 59] Inflammatory interleukins like IL-8, IL and IL6 are typically 
increased and anti-inflammatory interleukins alike IL-10 decreased in the BWE and 
oligofructose models. [60] Cell signaling is disrupted in the oligofructose and CHO models. 
Of particular note is that suppression of the Wnt signaling mechanism necessary for 
mesenchymal to epithelial transition of basal epithelial cells in the CHO model potentially 
interferes with commitment to the epithelial lineage necessary for organized epithelial tissue 
formation. [61] Basal cell gene expression of factors associated with both cell connections 
and communication like β-catenin and integrins in the CHO model and insulin growth factor 
receptor expression in the insulin model are reduced. [62, 63] Induction of laminitis in 
otherwise normal hooves is one mechanism to study the acute pathogenic mechanisms of the 
condition for potential therapeutic targeting. Unfortunately, the models do not exactly 
replicate the natural course of the disease that often includes persistent abnormalities in hoof 
tissue production and maturation. Focus on viable, immature cells that contribute to tissue 
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formation and repair is likely to reveal a new avenue of discovery in the quest to counteract 
the life-changing effects of laminitis.  
Table 1: Comparison of Microstructural Tissue Changes from Induced and Natural Laminitis. 
BWE: black walnut; CHO: carbohydrate overload; OF, oligofructose. 
 


















































Yes[52] Yes[54, 56] Yes[53, 70] Yes[25, 55] Yes[32] 
Calprotectin 
Positive Cells 
Yes[52] Yes[49] Yes[51] Yes[51] Yes[65] 
 
 
Figure 5. Fluorescent photomicrographs of the stratum internum from an unaffected (a) and 
laminitic (b) hoof with nucleii stained blue (DAPI). The lamellae are misshapen in the 





1.4. Multipotent progenitor cells and ectodermal progenitor cells 
Adult MSCs are routinely isolated from numerous tissues in the horse. [71, 72] Tissue stroma 
is derived from mesoderm, and undifferentiated cells in the space retain the capacity to alter 
their morphology and function to address the tissue repair and maintenance needs. [73] By 
definition, adult MSCs exhibit specific characteristics in vivo like the ability to adhere to 
polystyrene and the capacity to differentiate into distinct cell types from the same embryonic 
layer under specific induction conditions (Fig. 6). [74, 75] Additional criteria set by the 
International Society of Cell Therapy are the expression of some or all of a panel of surface 
antigens including CD105, CD44, CD29, CD73, CD90 and no expression of CD45, CD34, 
CD14, CD11b, CD19 as well as lineage-specific protein and gene expression following 
chemically-induced differentiation. [76, 77] Other stem cell markers often applied to identify 
MSCs include markers associated with embryonic development like octamer-binding 
transcription factor 4 (Oct-4), stage-specific embryonic antigen-3 (SSEA-3), stage-specific 
embryonic antigen-4 (SSEA-4) and podocalyxin (TRA-1-60). [78, 79] However, MSCs 
typically possess some capacity for self-renewal, though not immortality like totipotent cells, 
and they have variable immune-privilege. [80] 
Primary cell isolates are usually heterogenous collections of cells with multiple 
immunophenotypes that reflect different plasticity and maturity. [81] Despite this, the cells 
have characteristic microstructure and ultrastructure. [82] Current knowledge supports that 
progenitor cells can differentiate into distinct cells from similar origins as well from other 
embryonic layers, a process commonly referred to as transdifferentiation. [83] They also 
maintain the capacity to “regress” to an earlier stage of development both by natural and 
synthetic means. [84] Additionally, exogenous MSCs can both guide and be guided by 
endogenous cells. Despite similar behaviors and morphologies, undifferentiated cells vary 
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among species and tissues. [85] This requires individual characterization to elucidate the 
distinct properties and potential of cells from each parent tissue and species. [76, 77] 
The ability to culture and manipulate progenitor cells in vitro creates a plethora of 
opportunities to study normal and abnormal tissue regeneration to direct progressive 
therapeutic discovery and translation of cellular therapies. [86] Autologous and autogenous 
MSCs appear to promote tissue healing, including hoof, in horses and other species. [87] 
Despite this, epigenetic factors are thought to influence the plasticity of progenitor cells, with 
cells from a given tissue having the best potential to help repair that tissue. [88] Reports are 
mixed surrounding of the efficacy of non-tissue specific MSC therapies in the hoof and other 
tissues like the tendon, potentially due to the consequences of epigenetic programming that is 
not overcome by limited in vitro manipulation. [89-91] This evidence strongly supports the 
need to isolate and characterize progenitor cells from the hoof to understand the effects of 
inflammation on them as the potential of exogenous cells or neotissues to reverse or prevent 
the disease process. 
Flow cytometry and fluorescence activated cell sorting (FACS) are universal tools to quantify 
distinct cell characteristics within a heterogeneous progenitor cell isolate. Flow cytometry is 
used to differentiate cells based on size, volume and intensity of fluorescence from labeled 
antibodies that bind to antigens of interest on or within the cells. [92] The system is typically 
composed of a “flow” mechanism by which cells pass through a detection apparatus 
composed of a laser activator and light detectors. The light scatter is used to evaluate size and 
fluorescence detectors quantify light intensity within specific wavelength ranges. [93] FACS 
is a more complex form of flow cytometry that relies on most of the same concepts but has 
the added feature of sorting the cells based on size and fluorescence. To accomplish this an 
electrostatic charge is applied to fluid droplets containing individual cells. Based on the 
presence or absence of a charge, the cells are collected into distinct reservoirs. [94, 95] The 
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process of cell sorting is performed with live cells to allow culture following separation. The 
level of complexity varies among flow cytometry and FACS systems and can include 
relatively few to many detection channels to permit separation of cells expressing a wide 
assortment of proteins.  
 
Figure 6. Photomicrographs of laminar progenitor cells following culture in adipogenic (a), 
osteogenic (b) or neurogenic (c) induction medium as well as stromal medium (d, e, f). 
Adipose droplets(red), calcium deposits (red) and microtubule-associated protein 2 (Map2) 
protein expression (green) were stained with oil red O (a, d), alizarin red (b, e) and anti-map2 
with anti-mouse IgG (c, f), respectively. Nuclei were stained with DAPI (c, f, blue). 
 
Epidermal progenitor cells, are, as the name implies, derived from the embryonic ectoderm. 
[96] They inhabit the basal layer of the epidermis and participate in tissue repair and cyclic 
renewal under the direction of growth factors like epidermal and fibroblast growth factors. 
[97, 98] Like MSCs, they also possess the capability to differentiate in distinct cell lineages 
from multiple embryonic layers. [99] Notably, MSCs are reportedly capable of assuming an 
epidermal phenotype. Keratin composition changes with maturation stage well as specific 
function(s) (Fig. 7). [19] As cells mature from basal cells to transient amplifying cells, 
epidermal keratinocytes, and cornified epithelium, keratin expression changes. One example 
is the maturation of human epithelial progenitor cells that change keratin expression from 
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keratins 7,8,17,18, and 50 to keratins 6 and 16, followed by keratins 1 and 10, and finally 
keratins 2 and 9. [24, 100] Keratins 5, 15, and 19 are typically expressed by immature cells. 
[101] Human epidermal stem cells and transit-amplifying cells have been distinguished by 
high integrin-1β and low rhodamine binding versus low to medium integrin-1β expression 
and high rhodamine, respectively. As the progenitor cell knowledge base expands, so does 
awareness of distinctions between unique cell populations. [102] Continued diligence to 
maintain nomenclature and standards will support consistency and repeatability in progenitor 
cell research.  
Skin progenitor cells from most species have comparable plasticity to progenitor cells from 
other tissues and can mature into multiple lineages including bone, adipose tissue, nerve, and 
liver. [97, 103] Several immunophenotypes have been identified among species like K15+, 
CD34+ immature keratinocytes from canine hair-follicle tissue and CD29+, K19+ cells from 
human, murine and porcine skin.[98, 99] The markers CD34 and K6 are also used to identify 
and isolate keratinocytes. [104] Coexpression of keratins 15 and 19 by basal keratinocytes 
decreases with age and indicates cell self-renewal and tissue production capabilities in human 
skin. [101, 102] Fibroblast-like stem cells from human foreskin express CD90, CD105, 
CD166, and CD73 which are also found on human bone marrow derived MSCs. [105, 106] 
This information confirms a wide variety of epidermal progenitor cells within heterogeneous, 
primary cell isolates, establishes plasticity of the cells, and highlights common surface 
antigens with MSCs.  
Failure of basal cell proliferation or keratinocyte maturation are associated with mild to 
serious and potentially life-threatening skin pathology. [107] A study about human scalp hair 
follicle progenitor cells in bald versus hairy scalp showed that there was no difference in the 
number of K15+ progenitor cells, but that the number of CD200+, CD34+ cells was lower in 
bald scalp, leading to the conclusion that a failure or difference in maturation was the primary 
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distinction between the two conditions. [108] On the other end of the spectrum is 
epidermolysis bullosa, an inherited skin disorder in humans and horses associated in which 
depleted progenitor cells and disrupted homeostasis in the skin that as blistering or sloughing 
epidermis. [109] The underlying pathology of the disease is failure of anchoring proteins like 
laminin and collagen at the dermal-epidermal junction due to variable genetic mutations. [13, 
110] Injection of mesodermal or epidermal progenitor cells injected into lesions has 
reportedly promoted local healing of lesions. [111] This leads credibility to the potential for 
exogenous progenitor cells or cell factors to restore healing potential to damaged or 
compromised tissue.  
 
Figure 7. Fluorescent photomicrographs of cultured equine hoof progenitor cells stained with 
anti-K14 and anti-mouse IgG-488 (green). Nuclei are stained with Hoechst dye (blue). 
 
1.5. Hoof progenitor cells 
The epidermal-dermal interface in the stratum lamellatum is unique to the hoof in horses and 
the periodontal membrane and fingernail bed in humans. [112, 113] Isolation and culture of 
hoof progenitor cells has only recently been described in contrast to isolation of progenitor 
cells from the other interface tissues (Fig. 8). Current knowledge supports that primary 
progenitor cell isolates from normal and inflamed equine hoof stratum lamellatum express 
ectodermal (K14, K15, K19) and mesodermal (CD29, CD44, CD105) genes and proteins, and 
 15 
they have both ectodermal (neurogenic) and mesodermal (osteogenic, adipogenic) 
differentiation abilities. [114] Further, equine hoof progenitor cells share some ultrastructural 
features of both epidermal and mesodermal equine progenitor cells like intracellular vacuoles 
and well-developed dilated rough endoplasmic reticulum cisternae (mesodermal) and cell 
surface microvilli (ectodermal). [115, 116] Hoof progenitor cells also produce extracellular 
matrix on scaffold carriers composed of either polyester or mineral material and on 
decellularized lamellar matrix scaffold carriers in vivo, confirming the ability to form 
neotissue on custom templates. This suggests that in vitro cell models of the equine stratum 
internum may be an alternative This information suggests that in vivo induction of the 
condition in otherwise normal hooves.  
The description of equine hoof progenitor cell isolation is typical of collagenase tissue 
digestion for progenitor cell isolation from adipose tissue and skin with various collagenases 
(e.g., type I or type III), followed by separation of the cells from tissue remnants with 
combinations of filtration, gravity separation, and centrifugation. [117, 118] Notably, 
progenitor cells from cryopreserved, intact equine hoof stratum lamellatum have also been 
isolated by collagenase digestion. [119] Unlike cells isolated from cryopreserved periodontal 
ligament that were indistinguishable from fresh cell isolates, the cells from cryopreserved 
hoof tissue show signs of senescence including an irregular cell membrane, electron-dense 
cytoplasm, poorly organized rough endoplasmic reticulum, and aggregated chromatin (Fig. 9). 
[120] Cryopreservation is reported to “age” fresh cell isolates, and in vivo behavior, plasticity, 
growth rate and expansion potential are impacted accordingly. [121, 122] As such, most 
reports caution against consideration of continuously cultured and revitalized cells as the 
same. [120, 123] It is to distinguish between cryopreserved versus continuously cultured hoof 
progenitor cells as well as those isolated from fresh versus cryopreserved tissue given 
potential differences between them.    
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Figure 8. Stratum lamellatum harvested from an equine hoof (a) and the resulting cell pellet 
(b) after digestion, filtering and centrifugation. 
 
 
Figure 9. Transmission electron photomicrographs of cultured progenitor cells from fresh (a) 
and cryopreserved (b) equine stratum lamellatum. The cells from the cryopreserved tissue 
show signs of senescence.  
 
1.6. Transdifferentiation and regenerative medicine-scaffold 
Transdifferentiation is a complex process by which immature cells assume a new lineage that 
is distinct from their embryonic origin, parent tissue or current phenotype. [124] Numerous 
distinct and overlapping cell signaling pathways have been associated with 
transdifferentiation. Both mesodermal and epidermal progenitor cells possess 
transdifferentiation abilities as alluded to above. In mice and humans bone marrow progenitor 
cells can assume skin and neural phenotypes. [125, 126] Similarly, in horses, mesodermal 
progenitor cells from horse bone marrow show neural crest-like cell morphology and 
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expression of neural proteins after neural differentiation. A well-known transdifferentiation 
process is epidermal to mesenchymal transition (EMT). Controlled EMT is a key process in 
normal tissue healing, while uncontrolled EMT is characteristic of neoplasia. [127, 128] One 
caveat raised by researchers is that transitional cells, or cells expressing proteins from 
multiple lineages, must be thoroughly characterized to confirm their identity and avoid 
confusion with cells that result from fusion of stem cells with somatic cells. [129-132] 
Elucidation of the EMT process by hoof progenitor cells may provide novel insight to the 
pathology of laminitis. 
A natural interface between epidermis and dermis like that in human skin as well as equine 
hoof stratum lamellatum would reasonably contain transitional progenitor cells that can 
function in repair and maintenance of the complex tissue connection. [133] Recently, cells 
that express epidermal, K15, or mesodermal, CD105, proteins were identified in the stratum 
lamellatum. [119] Progenitor cell isolates that expressed both proteins were subsequently 
isolated from heterogenous stratum lamellatum primary cell isolates and cultured through 
multiple passages in vitro (Fig. 10). [116] The cells showed ectodermal and mesodermal 
plasticity and transdifferentiation capabilities. The potential for EMT to contribute to 
laminitis is suggested by the abundant mesodermal wedge of fibrous tissue typical of the 
condition. This is especially notable given the presentation of transitional cells in the stratum 
lamellatum. Inflammation has been shown to favor mesodermal tissue formation. [134] This 
leads credibility to the potential for inflammatory cytokine driven EMT in inflamed hooves. 
Given the potential for diverse neotissue formation, transitional progenitor cells may be a 
meaningful therapeutic target to help avoid permanent tissue damage and restore normal 
formation after an inflammatory insult in the equine hoof.  
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Figure 10. Transmission electron photomicrographs of P3 progenitor cells from equine hoof 
stratum lamellatum cultured on culture ware (a) and on decellularized lamellar tissue matrix 
(b). Gold-labeled secondary antibody labels (arrow) against K15 (10 nm) and CD105 (20 nm) 
localize in cell cytoplasm (a) and on the fibrous construct (b). 
 
Decellularized tissue matrix scaffolds are frequently used for in vitro and in vivo neotissue 
formation because they provide structural support and a favorable environment that contains 
various amounts of native tissue proteins to facilitate cell attachment and help guide 
differentiation. [135, 136] The matrices can be derived from virtually any tissue and are 
typically decellularized and partially deproteinized via chemical and thermal means in a 
variety of combinations. [137, 138] However, the tissue matrix does not necessarily have to 
come from the recipient species or tissue. Decellularized matrices have been used to support 
regeneration of tissues from relatively simple musculoskeletal structures to complex organs 
like liver. [139, 140] 
The complicated skin structure requires a matrix framework that recapitulates or facilitates 
formation of the epidermal-dermal junction during healing. Maturation of keratinocytes to 
form the protective, outer layers of skin relies on a healthy connection between the epidermis 
and dermis. [141] Synthetic and natural tissue matrices alone and with progenitor cells have 
been used to augment skin healing, and collagen-based matrices are widely popular. [134] A 
report details the use of porcine small intestinal submucosa matrix to treat granulating 
wounds on horse distal limbs. [142] MSCs from equine umbilical cord-blood embedded in an 
autologous fibrin gel were also found to improve the histologic outcomes of distal limb skin 
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wounds. [143] Dextran-based hydrogel scaffold improves neovascularization and skin 
regeneration in porcine burn wounds by promoting angiogenic cell infiltration and 
accelerating healing kinetics. [144] Porcine burn wounds treated with collagen-
glycosaminoglycan scaffold-MSC constructs had significantly better healing than with 
scaffold or cells alone. [145] While the hoof capsule has many differences from most of the 
epidermis, the work above establishes strong precedent for tissue matrix and tissue matrix-
cell based therapies to restore normal hoof growth and repair. 
Following severe inflammation, some changes in the basal membrane zone of the stratum 
lamellatum include altered keratinocyte proliferation, loss or reduction of vital proteins like 
laminin and collagen, and decreased cell hemidesmosome connections. Like other tissues, 
there appears to be abundant progenitor cells in damaged tissue. However, lack of structural 
and protein direction may prevent appropriate differentiation and, in fact, may misdirect 
differentiation via EMT. It is possible that minimally invasive implantation of decellularized 
stratum lamellatum (Fig. 11) or stratum lamellatum neotissue formed by progenitor cells 
under controlled laboratory conditions may provide the necessary clues for restoration of 
healthy hoof tissue. Continued in vitro research is necessary to advance and refine potential 
administration of exogenous tissue or cell-tissue constructs. 
 
Figure 11. Scanning electron micrograph of decellularized stratum lamellatum matrix 
showing the typical lamellar structure (a, arrow) and the surface of the structure (b).  
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1.7. The future of progenitor cell therapy  
Progenitor cell therapy has gained substantial popularity over the last few decades. Potential 
benefits of progenitor cells are abundant and include anti-inflammatory properties, direction 
of endogenous cells, and acceleration of tissue healing or formation, among others. Current 
Food and Drug Administration regulations, however, place strict regulations on preparation 
and administration of primary cell isolates. Potential concerns about their use include lack of 
a predictable half-life and route of elimination, the potential for undifferentiated cells to 
assume pathologic phenotypes, and possible, dangerous immune reactions. Despite this, 
promising results have been reported from primary cell administration. There are also 
valuable options for cell use. Some include living tissue models that recapitulate normal and 
abnormal embryonic tissue formation and generation of viable tissue grafts and organs for 
implantation from autogenous or biocompatible autologous progenitor cells. It is conceivable 
that neo-tissue models from hoof progenitor cells may provide a valuable resource for study 
and treatment of equine laminitis. The ability to create live tissue models of the sensitive hoof 
tissue will significantly advance its study. Culture conditions can be modified to replicate 
normal, diseased, and inflamed tissues to evaluate and modify cell responses to withstand and 
overcome tissue abnormalities from injury or systemic illness. In vitro neotissue models may 
also result in viable tissue grafts and support development of custom therapeutic matrix for 
local administration. Inherent to these futuristic, but theoretically attainable goal is the 
continued need to isolate and fully characterize native progenitor cell populations. It is only 
through focused, incremental advances that the infinite power of the cell can be harnessed to 
restore normal function of an organ or system for the health and well-being of a whole 
organism.   
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CHAPTER 2. IN VITRO CHARACTERISTICS OF HETEROGENEOUS 




Damage to an ectodermal-mesodermal interface like that in the equine hoof and human 
fingernail bed can permanently alter tissue structure and associated function. The purpose of 
this study was to establish and validate in vitro culture of primary progenitor cell isolates 
from the ectodermal-mesodermal tissue junction in equine hooves, the stratum internum, with 
and without chronic inflammation known to contribute to lifelong tissue defects. The 
following were evaluated in hoof stratum internum cell isolates up to 5 cell passages (P): 
expansion capacity by cell doublings and doubling time; plasticity with multi-lineage 
differentiation and colony-forming unit (CFU) frequency percentage; immunophenotype with 
immunocytochemistry, and flow cytometry; gene expression with RT-PCR; and 
ultrastructure with transmission electron microscopy. The presence of K15 and K19 as well 
as cluster of differentiation (CD)44 and CD105 was determined in situ with 
immunohistochemistry. To confirm in vivo extracellular matrix (ECM) formation, cell-
scaffold (polyethylene glycol/poly-L-lactic acid and tricalcium phosphate/hydroxyapatite) 
constructs were evaluated with scanning electron microscopy nine weeks after implantation 
in athymic mice. Cultured cells had characteristic progenitor cell morphology, expansion, 
CFU frequency percentage and adipocytic, osteoblastic, and neurocytic differentiation 
capacity. CD44, CD105, K15, and K19 proteins were present in native hoof stratum internum. 
Cultured cells also expressed CD44, CD105, K14, K15 proteins in addition to CD29, K19, 
and desmogleins 1 and 3. Gene expression of CD105, CD44, K14, K15, sex determining 
 *This chapter previously appeared as [Qingqiu Yang, Vanessa Marigo Rocha Pinto, Wei 
Duan, Erica E. Paxton, Jenna H. Dessauer, William Ryan and Mandi J. Lopez. “In vitro 
characteristics of heterogeneous equine hoof progenitor isolates”. Frontiers in Bioengineering 
and Biotechnology 7 (2019):155].  
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region Y-box 2 (SOX2) and octamer-binding transcription factor 4 (OCT4) was confirmed in 
vitro. Cultured cells had large, eccentric nuclei, elongated mitochondria, and intracellular 
vacuoles. Scaffold implants with cells contained fibrous ECM nine weeks after implantation 
compared to little or none on acellular scaffolds. In vitro expansion and plasticity and in vivo 
ECM deposition of heterogeneous, immature cell isolates from the ectodermal-mesodermal 
tissue interface of normal and chronically inflamed hooves are typical of primary cell isolates 
from other adult tissues, and they appear to have both mesodermal and ectodermal qualities 
in vitro. These results establish a unique cell culture model to target preventative and 
restorative therapies for ectodermal-mesodermal tissue junctions. 
The equine hoof is a complex anatomical structure that changed in size and shape as horses 
evolved from a multiple to a single toe ungulate [146-148]. Within a keratinized hoof wall, 
the last phalanx of the third digit is suspended by the stratum internum (lamellatum) [149], an  
attachment that can be permanently and fatally disrupted by inflammation within the hoof 
wall known as laminitis [110, 150-154]. Following damage, complex hoof architecture is 
replaced with abundant, poorly organized tissue [155, 156], and current treatments to restore 
normal tissue after disruption are largely unsuccessful [157].  
Tissue formation in the stratum medium, the cornified tissue layer directly above the stratum 
internum, results from basal cell proliferation in the coronary band [158] located at the 
proximal aspect of the structure. The cells undergo maturation into partially, keratinocyte, or 
fully, corneocyte, keratinized cells as they move downward from the basal layer.  Cells on the 
surface of the redundant, frond-like lamellae that constitute the ectodermal-mesodermal 
tissues in the stratum internum are connected to each other to form tight cell junctions [53, 
159]. As the ectodermal component of the tissue connected to the outer hoof wall grows 
downward relative to the mesodermal component fixed to the boney third phalanx via 
collagen fibrils, cells are thought to detach and reattach via controlled enzymatic activity, 
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largely within the basement membrane between them [12, 158]. While cell growth and 
maturation is well described for the cornified hoof tissue, the role of progenitor cells within 
the stratum internum to production and maintenance of the deeper hoof tissues, those at the 
ectodermal-mesodermal interface, are not well elucidated [29, 160].  
Isolation and characterization of progenitor cells from the ectodermal-mesodermal tissue 
niche of normal and inflamed, laminitic, hooves is necessary to advance understanding of cell 
behavior and reparative capacity under normal and inflamed conditions. [161, 162] 
Proliferating cells were identified in normal hoof lamellae with 5-bromo-2’-deoxyuridine 
(BRdU) [158]. Additionally, epithelial progenitor cells in the lamellae were localized by K14 
and transcription factor p63 expression [19, 34, 118, 163]. This information confirms that 
progenitor cells exist within the normal stratum internum. Altered progenitor cell behavior 
from disease and chronic inflammation disrupts tissue formation and healing in ectodermal-
dermal tissue interfaces like the periodontal membrane and fingernail bed [164-166]. A 
mechanism to confidently isolate and culture hoof progenitor cells from the ectodermal-
mesodermal tissue niche of normal and chronically inflamed hooves will provide a useful 
tool to evaluate mechanisms of cell damage and target therapies to prevent cell loss and 
restore normal growth following injury, local disease or systemic pathology. The purpose of 
this study was to establish and validate in vitro culture of progenitor cells from the stratum 
internum of equine hooves with and without chronic inflammation. 
2.2. Material and methods 
2.2.1. Ethics statement 
 
This work was funded in part by the Louisiana State University Equine Health Studies 




2.2.2. Study design 
Forelimbs from twenty two horses belonging to the University research herd, 14 unaffected 
(U) and 8 with laminitis (L), were disarticulated at the metacarpophalangeal joint following 
humane euthanasia for reasons unrelated to this study. Cells were isolated from the stratum 
internum and progenitor cells selected by plastic affinity. Outcome measures included cell 
expansion rate for cell passages (P) 1-3 (n = 5 U; n = 6 L), P1 trilineage differentiation (n = 3 
U; n = 3 L), P0, 2 and 5 colony forming unit frequency (CFU, n = 4 U; n = 3 L) and cell 
surface marker expression (n = 8 U; n = 7 L), hoof tissue immunohistochemistry (IHC) (n = 2 
U; n = 1 L), immunocytochemistry (ICC) of P1 and 3 (n = 2 U; n = 2 L), P0, 2 and 5 gene 
expression of CD44, CD105, K14, K15, octamer-binding transcription factor 4 (OCT4), and 
sex determining region Y-box 2 (SOX2) (n = 4 U; n = 5 L) and transmission electron 
microscopy (TEM) of P1 cell ultrastructure (n = 2 U; n = 2 L). Scanning electron microscopy 
(SEM, n = 1 U) was used to assess extracellular matrix (ECM) deposition on polyethylene 
glycol/poly-L-lactic acid (GA) and tricalcium phosphate/hydroxyapatite (HT) scaffolds 
loaded with P3 cells 9 weeks after subcutaneous implantation in athymic mice (Table 1).  
2.2.3. Radiographs  
Hooves were cleaned with soap and water and any shoes removed. Lateral digital radiographs 
were performed immediately after limb collection with a portable radiography unit (70 kVp, 
4l mAs, MiKasa X-ray Co, Japan) following placement of a radiopaque wire (length: 76.2 cm; 
diameter: 0.05 cm) on the dorsal midline of each hoof. A scale bar was included in 
radiographs to calibrate software tools used to make measures on digital images (Adobe 
Photoshop, version 5.5, Adobe Systems Inc., Seattle, WA). Dorsal rotation was quantified by 
subtracting the distance between the distal inner hoof wall and the third phalanx (P3) from 
the distance between the proximal hoof wall and P3 (Fig. 1) [167]. Sinking was the distance 
between the proximal portion of the coronary band and the extensor process of P3. 
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        Table 2. Horse Information and Study Assays I 
Age (year)     Condition Gender Breed Outcomes 
     CFU CD/DT ICC IHC PCR FC TEM  
3 Unaffected Gelding Thoroughbred X X      
8 Unaffected Mare Thoroughbred X X      
2 Unaffected Mare Thoroughbred X X      
4 Unaffected Gelding Thoroughbred X X      
13 Unaffected Mare Quarter Horse  X X     
3 Unaffected Gelding Thoroughbred     X X  
14 Unaffected Mare Quarter Horse      X  
9 Unaffected Gelding Tennessee 
Walker 
    X X  
7 Unaffected Mare Arabian    X X X  
7 Unaffected Gelding Paint Horse     X X  
22 Unaffected Gelding Palomino      X  













 X X 
17 Laminitic Gelding Quarter Horse  X   X X  
4 Laminitic Gelding Thoroughbred X X  X X X  
4 Laminitic Gelding Thoroughbred  X   X X  
19 Laminitic Gelding Thoroughbred  X    X  
13 Laminitic Mare Quarter Horse X X X  X X  









X   
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2.2.4. Tissue harvest  
Within 2 hours of harvest, hooves were cleansed with alternating washes of 10% sodium 
hypochlorite, sterile water and 0.1% chlorhexidine. With each lateral hoof surface gripped in 
a vice, two parallel cuts through hoof wall to bone were made 2 cm apart on the dorsal 
surface from coronary band to toe using a reciprocating saw and sterile blades (DC385, 
Dewalt®, Towson, MD). The cornified stratum externum and stratum medium between the 
cuts was elevated with a hoof nipper to expose the stratum internum. A square of 
approximately 2×2 cm was extracted from the midpoint of the dorsal surface with a #20 
scalpel blade. The tissue was rinsed with 0.01% chlorhexidine then soaked in phosphate 
buffered saline (PBS, Hyclone, Logan, UT) containing 1% antibiotic solution (MP 
Biomedical, Irvine, CA) for 15-30 minutes at room temperature.  
2.2.5. Cell isolation and culture  
In a sterile petri dish (NuncTM IVF petri dish, Thermo Fisher Scientific, Inc., Waltham, MA), 
tissue was minced into 1×1 mm squares using a #10 scalpel blade and then transferred to 50 
ml sterile tubes containing collagenase digest composed of 0.1% bovine serum albumin (BSA) 
(Sigma-Aldrich, St. Louis, MO) and 0.1% collagenase type-1 collagenase (Worthington 
Biochemical Corporation, Lakewood, NJ) in Dulbecco’s modified Eagle’s medium with 
Ham’s F12 nutrient mixture (DMEM-Ham’s F12, Hyclone). Samples in digest at a 1:2 tissue 
to digest (v/v) ratio were incubated at 37˚C for 2 hours with 3-dimensional agitation (5.5×g, 
GyroTwister™ GX-1000, LabNet, Inc., Edison, NJ). Subsequently, the digest was passed 
through a 100 µm followed by a 70 µm filter (Thermo Fisher Scientific) and then centrifuged 
at 260×g for 5 minutes. The stromal vascular fraction (SVF) was resuspended in stromal 
medium (DMEM-Ham’s F12, 1% antibiotic solution (MP Biomedical, Irvine, CA), 10% 
characterized fetal bovine serum (VWR Life Science, Radnor, PA)) and cultured on 10 cm 
culture plates (Corning Inc., Corning, NY). Medium was refreshed after 24 hours and then 
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every 3 days until 80% cell confluence. For study purposes, seeding density (5×103 cells/cm2), 
culture conditions (37˚C, 5% CO2), and plate confluence (80%) for cell detachment (0.05% 
trypsin, Hyclone) and passage were conserved throughout unless otherwise indicated.  
2.2.6. Colony forming unit frequency (P0, 2, 5) 
Limiting dilution assays were used to determine progenitor cell CFU frequency percentage 
by established methods [168]. Cells were added to a 48-well plate at 5×103, 2.5×103, 
1.25×103, 6.25×102, 3.12×102, and 1.56×102 cells/well in individual columns (8 replicates per 
cell number). After 7 days of culture in stromal medium, wells were rinsed with PBS and 
fixed with 1% paraformaldehyde (Sigma-Aldrich) in PBS at room temperature for 20 minutes 
followed by staining with 0.1% toluidine blue (Sigma-Aldrich) for one hour and a distilled 
water rinse. Digital images were obtained with an inverted phase contrast microscope 
(Olympus® CKX41SF, Japan) instrumented with a digital camera (Olympus DP21, Japan). 
Positive wells contained 10 or more stained colonies. The CFU frequency was calculated as F 
= e-x, where F = the ratio of negative to total wells, e = natural logarithm constant 2.71 and x 
= CFU number per well. The CFU frequency was expressed as a percentage (1/CFU 
frequency×100) [169, 170]. 
2.2.7. Cell doublings and doubling time (P1-3) 
Cell expansion was quantified in 12 well plates (Nunclon®, Sigma-Aldrich) as previously 
described [169]. Cell numbers were evaluated after 2, 4, and 6 days of culture using trypan 
blue exclusion and a hemocytometer. Cell doublings (CD) and doubling time (DT) were 
calculated as CD = ln(Nf /Ni)/ln(2) and DT = CT/CD where CT = culture time, Nf =  final cell 
number, and Ni = initial cell number. 
2.2.8. Multi-lineage differentiation (P1) 
Adipogenic, osteogenic and neurogenic differentiation was confirmed in cell isolates cultured 
in 6 well plates (Thermo Fisher Scientific). Cells were cultured in stromal medium for 5 days 
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to about 80% confluence followed by culture in induction medium. For adipogenesis, cells 
were cultured in adipogenic induction medium (DMEM-Ham’s F12, 3% FBS, 1% antibiotic 
solution, biotin (33 mmol/L), pantothenate (17 mmol/L), insulin (1 mmol/L), dexamethasone 
(1 mmol/L), isobutylmethylxanthine (IBMX, 0.5 mmol/L), rosiglitazone (5 mmol/L) (TZD, 
AK Scientific, Union City, CA), 5% rabbit serum (Invitrogen Corporation, Carlsbad, CA)) 
for 3 days followed by adipogenic maintenance medium (adipogenic medium without IBMX 
or rosiglitazone) for 2 more days. To confirm lipid accumulation, cells were fixed for 2 hours 
in 4% paraformaldehyde at room temperature and then stained with oil red O. To assess 
osteogenesis, cells were cultured in osteogenic induction medium (DMEM-Ham’s F12, 10% 
FBS, 1% antibiotic solution, β-glycerophosphate (1 mol/L), dexamethasone (20 nmol/L), 
sodium 2-phosphate ascorbate (50 mg/mL)) for 14 days and then fixed with 70% cold ethanol 
for 2 hours. Calcium in colonies was stained with 2% alizarin red in distilled water (pH 4.2) 
for 15 minutes at room temperature and then rinsed with distilled water [171]. Cells were also 
cultured in neurogenic pre-induction medium (DMEM, 10% FBS, 1 mM 2-mercaptoethanol) 
for 2 days followed by neurogenic induction medium (DMEM, 5.5 mM glucose, 120 µM 
indomethacin, 10% FBS, 3 µg/ml insulin, 300 µM IBMX) for 3 days. They were fixed with 1% 
paraformaldehyde overnight and then blocked with 10% goat serum for 1 hour at 37◦C. Cells 
were incubated with a mouse anti-microtubule-associated protein (MAP2) primary antibody 
(1:250) for 2 hours at 37◦C. They were then incubated with anti-mouse immunoglobulin G 
(IgG) secondary antibody labeled with Alexa Fluor 488 (1:1000) (Table 2) for 1 hour at room 
temperature. Controls included cells cultured in stromal medium and induced cells incubated 
with secondary antibody alone. Nuclei were stained with 4, 6-diamidino-2-phenylindole 
(DAPI, 1 μg/ml) for 10 minutes followed by a distilled water rinse. Photomicrographs were 
obtained with a camera (DFC480, Leica Microsystems, Germany) on a fluorescent 
microscope (DM 4500b, Leica Microsystems). 
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2.2.9. Immunohistochemistry (IHC), immunocytochemistry (ICC) (P1, 3) 
IHC (fluorescent)-Fresh tissue was embedded in optimal cutting temperature compound 
(OCT, Sakura Finetek Inc., Torrance, CA), solidified at -80°C, sectioned (5µm) with a 
cryostat (Leica® CM1850, Sarasota, FL), and applied to slides (poly L-lysine coated, Sigma-
Aldrich). Sections were blocked with 10% goat serum (Abcam Inc., Cambridge, MA) in PBS 
for 1 hour at room temperature after rehydration in PBS for 10 minutes. Slides were 
incubated with individual primary antibodies (CD29, CD44, K14, K19) (Table 2) diluted in 
tris-buffered saline (TBS, 1:200) at 37oC for 2 hours, rinsed with PBS, incubated with anti-
mouse IgG-Alexa Fluor 594 at 37oC for one hour in darkness, and then rinsed with PBS again. 
Nuclei were stained with Hoechst’s dye (Biotium, Hayward, CA), for 10 minutes at room 
temperature in darkness. Digital images were obtained with a fluorescent microscope (DM 
4500b, Leica) equipped with a digital camera (DFC 480, Leica). Unstained tissue and 
sections incubated with secondary antibody alone were included as control samples.  
IHC (chromogen)-Formalin fixed sections of laminae (1×0.5×0.5 cm) were paraffin 
embedded and sectioned (5 µm). Antigen retrieval was performed by incubating in citrate 
buffer (pH 6) for 30 minutes at 80°C. Sections were rinsed in PBS and endogenous 
peroxidase was blocked by incubation in 3% H2O2 for 30 minutes at room temperature. 
Nonspecific binding of antibodies was blocked by incubation with 1% BSA (Sigma-Aldrich) 
and 1% pre-immune serum (Abcam) in PBS for one hour at 37oC. Sections were then 
immunostained with murine anti-human antibodies against K14, K15 or K19 (Table 2) 
overnight at room temperature. After rinsing in PBS, sections were incubated with horse 
radish peroxidase (HRP) conjugated anti-mouse IgG (DAKO EnVision, Dako, Carpinteria, 
CA) for one hour at room temperature. Bound antibodies were then exposed with 
diaminobenzidine/H2O2 staining for three minutes at room temperature. Slides were 
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counterstained with hematoxylin and digital images captured with a light microscope 
(DM5000B, Leica) instrumented with a camera (DFC 480, Leica). 
ICC 
Cells were seeded on eight well multi-chamber slides (7×103 cells/well, Thermo Fisher 
Scientific). At approximately 70% confluence, cells were fixed in 4% paraformaldehyde. 
They were then permeabilized with 1.0% Triton-X100 (Sigma-Aldrich) in PBS for 10 
minutes at room temperature before blocking with 10% goat serum (Abcam) and 2% BSA 
(Sigma-Aldrich) in 1.0% Triton X-100. Cells were incubated with primary antibodies against 
desmoglein (DSG) 1, DSG3, K15 and K19 (Table 2) diluted 1:200 in the blocking solution 
above for 2 hours at 37˚C followed by goat anti-mouse IgG-Alexa Fluor 594 (1:1000, Table 2) 
at room temperature for 2 hours in darkness. Nuclei were stained with 4, 6-diamidoino-2-
phenylindole (DAPI). Photomicrographs were obtained with a fluorescent microscope (DM 
4500b, Leica) equipped with a digital camera (DFC 480, Leica). 
2.2.10. Flow cytometry (P0, 2, 5) 
Antibodies against K14, K15, K19, CD29, CD44 and MAP2 (Table 3) specific for equine 
antigens or validated for equine cross reactivity were used to label cells for flow cytometry. 
With the exception of MAP2, antibodies were were conjugated with FITC (FluoroTagTM 
FITC conjugation kit, Sigma-Aldrich). Cell aliquots (105 cells) were suspended in 800 ul of 1% 
BSA and 0.2% sodium azide in PBS containing 2 μl (200 ug/ml) of labeled antibody, and the 
mixture was incubated at room temperature for 30 minutes in darkness. Incubation with 
keratin antibodies was performed after cell permeabilization (Cytofix/CytopermTM kit, BD 
Biosciences, San Jose, CA). Following incubation with antibodies, cells were rinsed with 
PBS and fixed with 4% neutral buffered formalin. For MAP2 detection, cells were 
additionally cultured with anti-mouse IgG-Alexa Fluor 633 (Thermo Fisher Scientific). Cell 
fluorescence was quantified using a FACSCalibur flow cytometer (BD Biosciences, San Jose, 
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CA) and CellQuest graphics software (BD Biosciences). Unlabeled cells and isotype controls 
were included for all assays.  
Table 3. Antibodies Used for Heterogeneous Equine Hoof Progenitor Cells 
Antibody Label Description Cross/ 
Reactivity 
Host Manufacturer Catalog #. Diluent 
CD29 N/A 
 


























Mouse Abcam Inc 
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Rat, 
Human 
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2.2.11. RT-PCR (P0, 2, 5) 
Equine specific primers were designed for OCT4, SOX2, CD29, CD44, CD105, K15, DSG1 
and DSG3 (Table 4). Cells were detached from culture ware with 0.05% trypsin (Hyclone), 
rinsed with PBS and centrifuged at 260×g for 5 minutes. Total mRNA was isolated 
(RNAqueous Micro Kit Ambion, Inc., Austin, TX). Potential DNA contamination was 
removed by DNase I (Turbo DNA free, Ambion, Inc., Austin, TX) digestion. Samples were 
reverse transcribed into complementary DNA (cDNA) using oligo (dT) primers and Moloney 
Murine Leukemia Virus (M-MLV) reverse transcriptase (Sigma-Aldrich). Target gene 
mRNA levels were quantified with qRT-PCR using SYBR Green technology (Thermo Fisher 
Scientific) and an MJ Research Chromo4 Detector (Bio-Rad Laboratories, Hercules, CA). 
Amplicons were sequenced to confirm target sequence amplification. The ΔCt values were 
determined relative to the reference gene glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH).  
Table 4. Primer Sequences Information for Heterogeneous Equine Hoof Progenitor Cells 
Gene Forward  Reverse  Accession No. 
GAPDH  CAA TGA CCC CTT CAT TGA CC GAA GAT GGT GAT GGC CTT TC NM_001163856 
SOX-2 
OCT4 
CAG CTC GCA GAC CTA CAT GA 
TCG TTG CGA ATA GTC ACT GC 
TGG AGTG GGA GGA AGA GGT A 
AGT GAGA GGC AAC CTG GAG A 
XM_023623361 
XM_023624232 
CD29 CCA TTG TTC ACG TTG TGG AG TTG GCA AAT TCC CTT CTG TC XM_023631884 




CCC CAA GAG TCA ACA CCA CT 
 
TAC GAG ACG GAG CTG AAC CT 
 
GTT CGA GAC TGC AGG AGG AC 




K15 GTG GCT TTG GTG ACT TTG GT 
 
GTC TCG GAT CTT CAC CTC CA XM_005597407 
  
 
2.2.12. In vivo extracellular matrix production (P3) 
Scaffold carriers composed of polyethylene glycol/poly-L-lactic acid (60:40, GA) and 
tricalcium phosphate/hydroxyapatite (40:60, HT) were fabricated by thermally induced phase 
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separation as previously described [172]. P1 Equine laminar progenitor cells form U hooves 
were cryopreserved in liquid nitrogen in custom medium (10% dimethyl sulfoxide, 10% 
DMEM/F-12, 80% FBS) after being gradually cooled to -80oC (-1oC/minute, CoolCell®, 
BioCision, Larkspur, CA). They were then culture expanded to P3 and loaded (6.3×103 
cell/mm3) onto scaffolds (diameter: 10 mm; depth: 3 mm) for 2 hours at 70 rpm stirring in a 
spinner flask (Bellco® Biotechnology, Newark, NJ) containing 120 ml of serum-free stromal 
medium. Cells that remained in the medium were quantified to estimate the number of cells 
on the scaffolds. Scaffolds without cells were treated identically to those with cells prior to 
implantation. Six equal pieces of each scaffold were surgically implanted in the dorsal 
subcutaneous tissues of 4 (n = 6 implants/mouse) male athymic mice (nu/nu, Charles River 
Laboratories, Wilmington, MA). One mouse received six individual pieces of an HT cell-
scaffold constructs, a GA cell-scaffold constructs, an HT scaffolds only, or a GA scaffold 
only.  
For the implantation procedure, mice were premedicated with glycopyrrolate (0.02 mg/kg) 
and butorphanol (0.5 mg/kg) and subsequently anesthetized with isoflurane on oxygen 
delivered via a Baine circuit and mask. Following aseptic preparation, 6 skin incisions (5 
mm) were created equidistantly along the dorsum extending from the scapula to the sacrum, 
approximately 1 cm lateral to each side of the spine, and scaffolds were placed after minimal 
blunt dissection. Subcutaneous tissues were closed with monocryl (Monocryl®, Cornelia, 
GA) and skin apposed with tissue glue (Sigma-Aldrich). Nine weeks after implantation, 
explants were fixed with 2.5% glutaradehyde in 0.1M sodium carcodylate buffer, post-fixed 
with 0.1% osmium tetroxide, and dehydrated in a series of ethanol-distilled water solutions. 
After critical point drying, constructs were sputter coated with gold and imaged with a 
scanning electron microscope at 15 kVP (FEI Quanta 200, Netherlands) [173]. 
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2.2.13. Transmission electron microscopy (P1) 
Cells at 80% confluence were detached and centrifuged at 260×g for 5 minutes at room 
temperature. Pellets (3×106 cells/pellet) were fixed with 1.6% paraformaldehyde, 2.5% 
glutaraldehyde, 0.03% CaCl2 in 0.05M cacodylate buffer (pH 7.4), washed in 0.1M 
cacodylate buffer supplemented with 5% sucrose and post fixed in 2% osmium tetroxide for 
1 hour. They were washed with distilled water and incubated in a 1% water solution of tannic 
acid for 1 hour. Following dehydration with propylene oxide in ascending ethanol 
concentrations, pellets were embedded in Epon-Araldite (EMS, Hatfield, PA). Blocks were 
sectioned (80-90 nm, Ultratome Leica EM UC7, Germany) and stained with 2% uranyl 
acetate in maleate buffer and lead citrate. Images were generated with a digital camera 
(Hamamatsu ORCA-HR, Japan) on an electron microscope (JEOL JEM 1011, Japan). All 




Capsular rotation was 1.0 ± 1.4 mm (mean ± SEM) and 3.7 ± 1.7 mm, and distal descent 9.0 
± 0.8 mm and 10.6 ± 3.7 mm in U and L hooves, respectively (Fig. 12).  
 
Figure 12. Radiographs of an unaffected (A) and a laminitic hoof (B) demonstrating where 




2.3.2. Cell isolation and culture 
Cell yield was 1.34×107 ± 1.25×106 and 1.70×107 ± 3.05×106 nucleated cells/g from U and L 
hoof tissue, respectively. Primary cell isolates from all hooves exhibited a rhomboid shape 
after 2 days of culture (Fig. 13 A, B). After one week’s culture, most cells from unaffected 
and laminitic hooves had a typical spindle shape consistent with progenitor cell morphology 
(Fig. 13 C, D).  
 
Figure 13. Light photomicrographs of equine hoof progenitor cells from unaffected (A, C) 
and laminitic hooves (B, D) after 2 (A, B) and 7 days (C, D) of culture. Bar = 500 μm 
 
2.3.3. Colony forming unit frequency (P0, 2, 5)  
The CFU frequency percentages tended to increase with increasing passage (Fig. 14). They 
were 0.05% ± 0.04%, 0.17% ± 0.07% and 0.32% ± 0.31% for passages P0, 2 and 5, 
respectively, for progenitor cells from U hooves. For the same cell passages from L hooves, 
CFU frequency percentages were 0.20% ± 0.09%, 0.10% ± 0.06% and 0.41% ± 0.21%.  
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Figure 14. Colony forming unit frequency percentages (mean ± SEM) for P0, 2, and 5 
progenitor cells from unaffected and laminitic hooves.   
 
2.3.4. Cell doublings and doubling time (P1-3) 
The rate of in vitro expansion tended to increase with passage. Cell doubling values for P1, 
P2 and P3 for cells from U hooves were 0.55 ± 0.65, 2.04 ± 1.20 and 1.58 ± 0.57 versus 0.85 
± 0.50, 1.88 ± 1.10 and 1.99 ± 1.20 for the same passages from L hooves (Fig. 15 A). 
Doubling times for P1, P2 and P3 cells from U hooves were 0.26 ± 0.15, 0.12 ± 0.07 and 0.20 
± 0.11 days/CD versus 0.32 ± 0.19, 0.13 ± 0.07 and 0.12 ± 0.07 days/CD from L hooves (Fig. 
4 B). Growth curve represented by cell numbers for P1, P2, P3 cells from U and L hooves as 
well (Fig. 15 C). 
 
Figure 15. Cell doublings (A), doubling times (B), growth curve with cell numbers (C) (mean 





2.3.5. Multi-lineage differentiation (P1) 
Passage 1 progenitor cells from U and L hooves all displayed characteristic adipocytic (Fig. 
16 A), osteoblastic (Fig. 16 B) and neurocytic (Fig. 16 C) differentiation following culture in 
differentiation medium based on histochemical or immunocytochemical staining. Cells 
cultured in stromal medium for identical time periods did not differentiate (Figs. 16 D-F).  
 
Figure 16. Photomicrographs of P1 laminar progenitor cells cultured in adipogenic (A), 
osteogenic (B), neurogenic (C) or stromal (D-F) medium and stained with oil red O (A, D), 
alizarin red (B, E) or anti-map2, anti-mouse IgG-488 (green). DAPI nuclear stain (blue, C, F). 
Magnification = 20X, Bar = 100 μm 
 
2.3.6. Immunohistochemistry (IHC), immunocytochemistry (ICC) (P1, 3) 
Both fluorescent (Fig. 17) and chromogen (Fig. 18) immunohistochemical labeling confirmed 
the presence of CD44, CD29, K14 and K19 in the stratum internum of both U and L hoof 
tissue. Based on immunocytochemical staining, P1 and 3 cultured cells from U and L hooves 
expressed DSG1 and DSG3 (Fig. 19) as well as K15 and K19 (Fig. 20).  
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Figure 17.  Fluorescent photomicrographs of primary and secondary epidermal lamellae from 
an unaffected hoof labeled with antibodies (red) against K14 (A), K19 (B), CD44 (C), 
andCD29 (D). Control sections were stained only with secondary antibody (E). Nuclei were 
stained with Hoechst nuclear dye (blue). PEL = primary epidermal laminae; SEL = secondary 
epidermal laminae. Arrows = stained cells; Magnification = 40X, Bar = 50 μm 
 
 
Figure 18. Light photomicrographs of lamellae from unaffected (A, B) and laminitic (C, D) 
hooves labeled (brown) with antibodies against K14 (A, C) and K15 (B, D). PEL = primary 
epidermal laminae; SEL = secondary dermal laminae; Arrow = labeled cells; Magnification = 




Figure 19. Fluorescent photomicrographs of cultured progenitor cells (P3) from unaffected (B, 
D) and laminitic (A, C) hooves labeled (red) with anti- DSG1 (A, B) or DSG3 (C, D) 
antibodies. Control cells were stained only with secondary antibody (E). Nuclei were stained 
with DAPI (blue). Magnification = 40X 
 
 
Figure 20. Fluorescent photomicrographs of cultured hoof progenitor cells (P1) from 
unaffected (A, B) and laminitic (C, D) hooves after labeling (red) with antibodies against 
K15 (A, C) or K19 (B, D). Control cells cultured with stromal medium were stained only 





2.3.7. Flow cytometry (P0, 2, 5)  
Passage P0, 2 and 5 cultured progenitor cells from U and L hooves expressed CD29, CD44, 
CD105, K14, K1 and K19 (Fig. 21). The percentage of cells expressing CD105 or CD44 (Fig. 
21 B, C) tended to decrease with passage while the percentage expressing CD29 (Fig. 21 A) 
remained fairly constant across passages. The majority of P2 and 5 from both hoof conditions 
expressed K14, K15 and K19 (> 90%) (Figs. 10 D-F). Approximately 80% of cells cultured 
in neurogenic induction medium expressed MAP2 compared to 18% of cells cultured in 
stromal medium, and the peaks for unlabeled, stromal and differentiated cells had distinct 
histogram peaks (Fig. 22).  
 
Figure 21. Flow cytometry histogram showing MAP2 labelling of P1 equine hoof progenitor 
cells from an unaffected hoof cultured in stromal (Stromal MAP2) or neurogenic medium 
(Neurogenic MAP2), and autofluorescence of unlabeled cells cultured in neurogenic medium 
(Neurogenic Auto, A). Percentage (mean ± SEM) of P1 hoof progenitor cells from unaffected 
hooves expressing MAP2 after culture in stromal (Stromal) or neurogenic (Neurogenic) 




Figure 22. Flow cytometry histogram showing MAP2 labelling of P1 equine hoof progenitor 
cells from an unaffected hoof cultured in stromal (Stromal MAP2) or neurogenic medium 
(Neurogenic MAP2), and autofluorescence of unlabelled cells cultured in neurogenic medium 
(Neurogenic Auto, A). Percentage (mean ± SEM) of P1 hoof progenitor cells from unaffected 
hooves expressing MAP2 after culture in stromal (Stromal) or neurogenic (Neurogenic) 
induction medium. Hoof progenitor cells from unaffected hooves expressing MAP2 after 
culture in stromal (Stromal) or neurogenic (Neurogenic) induction medium. 
 
2.3.8. RT- PCR (P0, 2, 5) 
Gene expression of CD44, CD105, K14, K15, OCT4 and SOX2 by P0, 2 and 5 progenitor 
cells from U and L hooves was confirmed (Fig. 23). Gene expression was relatively similar 
between conditions and stable across passages. Exceptions included an apparent decrease in 
K14 expression with increasing passage in cells from U hooves and an increase in CD44 
expression with increasing passage in cells from L hooves. The stability of the reference gene, 
GAPDH, was confirmed by a CT value of 17.71 ± 0.20 for all samples. 
2.3.9. In vivo extracellular matrix production (P3) 
Approximately 5.60×103 cells/mm3 were loaded onto each scaffold. Abundant collagen 
fibrils and organized ECM was apparent on scaffolds containing cells (Fig. 24 A, B), while 




Figure 23. Expression levels (ΔCT, mean ± SEM) of CD44 (A), CD105 (B), K14 (C), K15 
(D), OCT4 (E) and SOX2 (F) in progenitor cells from unaffected (U) and laminitic (L) 
hooves at the indicated passages. Reference gene: GAPDH; SOX2 = SRY (sex determining 
region Y)-box 2; OCT4 = octamer-binding transcription factor 4 
 
 
Figure 24. Scanning electrophotomicrographs of scaffold constructs with (A, B) and without 
(C, D) P3 equine hoof progenitor cells from an unaffected hoof 9 weeks after subcutaneous 
implantation in athymic mice. Arrow = collagen fibrils; Arrowhead = organized extracellular 
matrix; Magnification = 6000X (A, C); 3000X (B, D)   
 
2.3.10. Transmission electron microscopy (P1) 
Cell ultrastructure was similar between cells from U and L hooves. Large, irregular, eccentric 
nuclei, elongated mitochondria, rough endoplasmic reticulum surrounded by cisternae, and 
randomly distributed cytoplasmic vacuoles were present in all cells evaluated (Fig. 25). 
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Figure 25. Transmission electromicrographs of progenitor cells (P1) from normal (A, B) and 
laminitic (C, D) hooves. Black arrow = vacuole; White arrowhead= nucleus; Black 
arrowhead = mitochondria; White arrow = rough endoplasmic reticulum; Magnification = 
10,000X (A, C), 20,000X (B, D)  
 
2.4. Discussion 
The work in this study establishes a reproducible mechanism to isolate and culture progenitor 
cells from unaffected and chronically inflamed ectodermal-mesodermal tissue of the equine 
hoof, a tissue interface similar to the human and mouse periodontal membrane and the human 
fingernail [174, 175]. In vitro culture of adult progenitor cells provides a mechanism to 
evaluate cell behavior under distinct conditions [176-179] to assess cell alterations mediated 
by chronic inflammation or disease. The methods will support cell and tissue culture for 
investigation of mechanisms to prevent or address pathogenic processes in ectodermal-
mesodermal tissue. This work establishes a unique an important model to study progenitor 
cells in the distinct ectodermal-mesodermal niche, a site of important health challenges in 
both veterinary and human patients [180, 181].  
Plastic adherence of the cells in this study is consistent with cell immaturity and multi-
lineage differentiation confirms plasticity [182-184].  Progenitor cells from both inflamed and 
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unaffected tissues showed similar in vitro behavior as equine progenitor cells from normal 
adult tissues [184-187], and characteristics appeared to be maintained through numerous 
passages [188]. Notably, mesodermal and ectodermal cell differentiation suggests the 
presence of cells from different lineages, cells capable of transdifferentiation, or, most likely, 
both given the heterogenous composition of the isolates.  In vitro expansion rates of about 0.3 
days/CD in this study was slightly higher than those reported for bone marrow, adipose and 
umbilical cord derived equine MSCs of about 1 day/CD [189] and human epidermal 
keratinocytes of about 0.7 days/CD [190]. Distinct culture conditions and natural variation 
typically contribute to differences in expansion behavior among studies [191, 192]. The CFU 
frequency percentages in this study are comparable to those from mesodermal and 
ectodermal equine progenitor cells of about 0.6% and 1.5%, respectively [79, 193]. Taken 
together, these results confirm the immaturity of the heterogeneous primary cell isolates. 
The presence of mesodermal and ectodermal proteins in hoof tissue and within heterogeneous 
cell isolates in vitro is important to translate information between in vitro and in vivo 
conditions [194-202]. A prominent goal of this series of investigations was to validate 
parallel protein expression in cultured primary cell isolates and tissue. Despite a plethora of 
methods to culture progenitor cells from numerous tissues of most species, localization of 
progenitor cell antigens in situ and in vitro is rare [203, 204]. The fact that the cell isolates 
retained their characteristics in culture based on flow cytometry results is especially vital to 
the validity of the culture model. Results of this study are limited to cells that have been 
passaged beyond the initial stromal vascular fraction isolate. Culture of cells under ideal 
conditions can potentially mask natural attributes and behaviors, a recognized limitation of 
cell culture and impetus to maintain culture conditions that replicate distinct natural states 
[205].    
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The ability of cells within heterogeneous primary cell isolates to mature into distinct lineages 
in this study is consistent with current knowledge surrounding cell plasticity, especially in 
tissue interfaces [206-208]. As indicated above, it is likely that the junction between 
epidermal and dermal tissues contains progenitor cells from ectodermal and mesodermal 
embryonic layers, and, potentially, transitional cells that have characteristics of both tissue 
types permitting ready transdifferentiation [209]. Additional work is needed to isolate and 
characterize specific cell immunophenotypes from heterogeneous primary cell isolates.  
Tight cell junctions that stabilize the ectodermal-mesodermal tissue interface are composed 
of a variety of proteins like desmogleins, cadherins, laminins and E-selectins, among others 
[210]. Desmogleins are major proteins of desmosomes, cell to cell junctions [211], and 
hemidesmosomes, cell to tissue or ECM junctions. Loss of desmoglein integrity or 
diminished production is associated with sloughing of the epidermis [212-215] and abnormal 
tissue production [216, 217]. There are fewer hemidesmosomes along the basement 
membrane between the ectodermal and dermal layers in inflamed versus normal equine hoof 
tissue [218]. Future studies using cell culture may further confirm the potential for disruption 
of desmoglein function or production by inflammation.  
The cells in this study shared some ultrastructural features with equine and human adult 
multipotent cells including polymorphic nuclei, well-developed dilated cisternae of rough 
endoplasmic reticulum, intracellular vacuoles and elongated mitochondria [219-223]. High 
metabolic activity typical of immature cells is suggested by elongated mitochondria [224]. 
Intracellular vacuoles are associated with protein recycling [225, 226], and they are thought 
to be filled with proteinaceous material destined for secretion in human adult stem cells from 
bone marrow [227, 228]. There are also reports of small cytoplasmic vacuoles in Merkel cells 
within canine whisker pad basal epidermis [229, 230]. The ultrastructure of the cells reported 
here is consistent with high metabolic activity of progenitor cells and a secretory function 
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typically associated with keratinizing cells [231]. The results are not consistent with any one 
cell type and likely reflects heterogeneous nature of the cell isolates.  
Abnormal tissue formation in inflamed ectodermal-mesodermal interface tissues has been 
reported to be the result of altered maturation  [203, 232-236]. As such, appropriate cell 
direction is essential for stem cell transplantation therapies to drive restorative tissue 
formation [237, 238]. The present study was not designed to assess treatment outcomes in 
contrast to clinical reports of stem cell therapies [239, 240] or to compare characteristics of 
cells from normal and inflamed tissue, but to establish a model of cell culture that 
accommodates cells from both tissue conditions. Robust, organized ECM formation by hoof 
progenitor cells on scaffold carriers confirms the translational potential of the  cell isolates 
from this study [241] comparably to published information[242]. However, future work is 
necessary to formulate scaffold carriers to direct hoof progenitor cell differentiation in vivo or 
support hoof tissue formation in vitro to create implantable graft tissue that guides native 
progenitor cells [243, 244]. Evaluation of the broad cell signaling pathways represented by 
OCT4 and SOX2 in primary cell isolates cultured under conditions that replicate native tissue 
may be natural starting points for study of mechanisms to modulate cell behaviors in tissue 
constructs [245-248]. In the future, de novo tissue formation with progenitor cells may 
provide a new therapeutic option for chronic conditions of the ectodermal-mesodermal 
interface. 
The authors recognize several limitations of this preliminary study to establish isolation and 
culture of progenitor cell isolates from an ectodermal-mesodermal interface. Cell isolates are 
heterogeneous, so work is necessary to isolate and evaluate unique progenitor cell 
immunophenotypes given that characteristics of a cell population reflect but are not identical 
to those of individual cells [249]. Also, as pointed out above, the initial 2D cell culture in 
mesodermal basal medium as well as the isolation process very likely selected for distinct 
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progenitor cell populations that may have stronger mesodermal than ectodermal predilections 
[222, 250, 251]. Selection of cell immunophenotypes and subsequent culture in mesodermal 
and ectodermal basal medium will provide important information about the novel progenitor 
cells residing in the ectodermal-mesodermal interface. Nonetheless, the presence of 
mesodermal and ectodermal antigens and differentiation potential over multiple cell passages 
confirm that cells of both embryonic origins survived under the culture conditions employed 
in this study.   
Progenitor cell isolates from the ectodermal-mesodermal tissue interface of the equine hoof 
display characteristics of both tissue types and maintain progenitor qualities through multiple 
in vitro cell passages. The cells are present in both normal and inflamed tissue and key 
protein antigens, including those in cell to cell and cell to tissue junctions, are retained in 
culture. Hoof progenitor cells promote collagenous extracellular matrix formation on distinct 
scaffold carriers in vivo, confirming future opportunities for cell directed tissue formation. 
Results from this study set the stage for work to ascertain mechanisms by which 
inflammation impacts progenitor cells in the ectodermal-mesodermal niche. Methods to 
direct appropriate cell differentiation and tissue formation will provide new therapeutic 










CHAPTER 3. ULTRASTRUCTURAL MORPHOLOGY IS DISTINCT 
AMONG PROGENITOR CELLS ISOLATES FROM NORMAL, 
INFLAMED AND CRYOPRESERVED EQUINE HOOF TISSUE AND 
CD105+K14+ PROGENITOR CELLS* 
 
3.1. Introduction 
The equine hoof dermal-epidermal interface requires progenitor cells with distinct 
characteristics. This study was designed to provide accurate ultrastructural depictions of 
progenitor cells isolated from inflamed tissue and normal tissue before and after 
cryopreservation and following selection of cells expressing both K14 (ectodermal) and 
cluster of differentiation (CD) 105 (mesodermal). Passage 3 cell ultrastructure was assessed 
following 2D culture and after 3D culture on decellularized hoof tissue scaffolds. Outcome 
measures included light, transmission electron, and scanning electron microscopy, and 
immunocytochemistry. Cells from normal tissue had typical progenitor cell characteristics. 
Those from inflamed tissue had organelles and morphology consistent with catabolic 
activities including lysosomes, irregular rough endoplasmic reticulum and fewer vacuoles 
and early endosomes than those from normal tissue. Cryopreserved tissue cells appeared 
apoptotic with an irregular cell membrane covered by cytoplasmic protrusions closely 
associated with endocytic and exocytic vesicles, chromatin aggregated on the nuclear envelop, 
abundant, poorly organized RER and plentiful lysosomes. Cells that were K14+, CD105+ 
were distinguishable from heterogenous cells by infrequent microvilli on the cell surface, 
sparse endosomes and vesicles, and desmosomes between cells. Cells expressed ectodermal 
(K15) and mesodermal (CD105) proteins in 2D and 3D culture. Inflamed and cryopreserved 
tissue isolates attached poorly to tissue scaffold while normal tissue cells  
* This chapter previously appeared as [Qingqiu Yang and Mandi J. Lopez. “Ultrastructure 
morphology is distinct among progenitor cell isolates from normal, inflamed, and 
cryopreserved equine hoof tissue and CD105+K14+ progenitor cells” In Vitro Cellular & 
Developmental Biology-Animal 9 (2019): 1-15].  
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attached well, but only K14+, CD105+ cells produced extracellular matrix after 4 days. The 
ultrastructural information provided by this study contributes to understanding of equine hoof 
progenitor cells to predict their potential contributions to tissue maintenance, healing and 
damage as well post-implantation behavior.  
The equine hoof originates from a dermo-epidermal anlage to form what is considered one of 
the most complex mammalian integumentary structures [252]. A branched, interdigitating 
interface between the epidermal and dermal layers, the lamellar stratum internum, suspends 
the bony third phalanx from the cornified hoof capsule [146, 149]. The interface both 
withstands the physiologic forces of ambulation and participates in hoof tissue homeostasis 
[253]. The unique tissue architecture composed of redundant, dermal and epidermal tissue 
extensions creates an expansive surface area with innumerable cell tight junctions within 
minimum volume. Inflammation of the stratum internum, laminitis, has severe consequences 
on the tissue’s structural integrity and can cause permanent disfigurement and compromised 
function [254, 255]. 
Ultrastructural features are invaluable to understanding cell activities, interactions, and 
identity, as well as the consequences of pathology [256, 257]. Ultrastructure of the stratum 
internum, including desmosome cell junctions and a basement membrane interface between 
epidermis and dermis is described [12, 258] as are pathologic changes in post-mortem 
samples from naturally occurring and artificially induced inflammation [53, 55]. However, 
viable, cultured hoof cell morphology is vitally important to understanding both normal and 
pathologic behavior and signaling. To date, ultrastructural evaluation of the cellular 
component of the lamellar tissue interface is largely unexplored [34].   
Knowledge about cells that occupy the unique dermal-epidermal niche are primarily limited 
to human skin and nail bed, and there is a dearth of information about those cells that reside 
in the same interface within the equine hoof. Transitional progenitor cells that share features 
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of the transitional epithelium exist among basal cells at the squamous-columnar junction in 
the mouse upper gastrointestinal tract [259]. The cells are thought to play a central role in 
tissue maintenance, including the basement membrane of the dermal-epidermal junction 
[253]. Comprehensive ultrastructural information is needed to fully elucidate the progenitor 
cell population of the equine hoof dermal-epidermal interface. 
A notable consideration for contemporary progenitor cell biology is the challenges of 
distance and associated time between tissue harvest and processing sites. Cryogenic tissue 
and/or cell preservation are frequently required [260]. Cryopreservation is known to alter the 
behavior and morphology of progenitor cell isolates [121], though surrounding tissues are 
thought to provide some protection to cells in vessel and bone tissue during stasis [261, 262]. 
Direct comparison of cell isolates from fresh and cryopreserved tissue helps predict 
morphologic changes manifest by cryogenic preservation.  
Decellularized tissue templates that provide a natural tissue niche to instruct exogenous 
progenitor cells are popular for de novo tissue generation [263, 264]. The quantity and 
organization of extracellular matrix produced by progenitor cells on tissue templates is often 
used to discern cell neotissue forming capabilities [265]. Cell-scaffold interactions that drive 
matrix deposition, composition and organization vary among cell morphologies as evidenced 
by unique responses among progenitor cells from different tissues to identical decellularized 
scaffold [266-269]. Behaviors also vary between cells from normal and inflamed tissues 
[270]. Additionally, a strong predictor of progenitor cell potential for functional tissue 
formation is preservation of characteristics in both 2D and 3D culture [205]. As such, 
evaluation of hoof progenitor cell behavior on decellularized laminar tissue provides a natural 
foundation for de novo hoof tissue generation and anticipation of in vivo behavior [267].  
Recent studies support the promise and potential of progenitor cells to contribute to and 
direct bone tissue formation in vitro and in vivo [271, 272]. Differences among species, 
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progenitor cell tissue sources, and freezing techniques preclude assumptions or predictions 
about progenitor cells without explicit evaluation [273, 274].  
This series of investigations provides essential details about the in vitro ultrastructure of 
equine hoof progenitor cells from normal, inflamed, and cryopreserved tissue. The 
ultrastructure of a novel transitional progenitor cell immunophenotype is also presented. 
Potential for generation of 3-D cell-tissue template constructs is explored by ultrastructural 
assessment of cultured progenitor cells of each description on decellularized stratum 
internum tissue templates. In all, the objective of the work is to provide novel and accurate 
depictions of progenitor cells isolated from the unique dermal-epidermal niche of equine hoof 
tissue exposed to distinct and meaningful conditions. 
3.2. Materials and methods 
3.2.1. Ethics statement 
This study is supported by the Louisiana State University Equine Health Studies Program 
(EHSP) and United States Department of Agriculture (USDA). 
3.2.2. Tissue harvest  
Cells were harvested immediately post-mortem from 6 horses (Table 1) with and without a 
history of chronic laminitis that were humanely euthanized for reasons unrelated to this study. 
Briefly, following aseptic preparation of the hoof surface, the stratum internum was exposed 
by elevation of the cornified hoof wall between two parallel, full thickness cuts 
(approximately 6 cm apart) extending from proximal to distal on the dorsal hoof. Two 
contiguous regions of stratum internum (2 x 2 cm) were sharply excised with a sterile #20 
scalpel blade, and, following a rinse with 0.01% chlorhexidine, maintained in phosphate 
buffered saline (PBS, HycloneTM, Logan, UT) containing 1% penicillin at 4˚C for 
approximately 1 hour. One sample was then placed in 1 ml cryopreservation medium (10% 
dimethyl sulfoxide (DMSO), 10% Dulbecco’s modified Eagle’s medium with Ham’s F12 
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nutrient mixture (DMEM-Ham’s F12, Hyclone, Logan, UT), 80% fetal bovine serum (FBS, 
VWR Life Science, Radnor, PA)) within a microvial (Fisher Scientific, Denmark), and 
cooled to -80˚C at which they there maintained for one week (CoolCellTM LX, BioCision, 
Tewksbury, MA).  
3.2.3. Cell isolation and culture  
Cryopreserved tissue was thawed at room temperature for 5 minutes and washed three times 
with PBS to remove cryopreservation medium. Fresh and thawed tissue was diced into cubes 
(5 mm x 5 mm) and added to 50-ml sterile tubes containing 0.1% collagenase digest (0.1% 
bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO), 0.1% collagenase type-1 
(Worthington Biochemical Corporation, Lakewood, NJ) in DMEM-Ham’s F12 medium) at a 
ratio of 1:2 tissue to digest (v/v). Digests were maintained at 37˚C for 2 hours with 3-
dimensional agitation (5.5 ×g, GyroTwister™ GX-1000, Labnet, Inc., Edison, NJ). The 
mixture was passed through a 100-µm followed by a 70-µm filter (Fisher Scientific, Waltham, 
MA) and centrifuged at 260 ×g for 5 minutes. Cell pellets were suspended in stromal culture 
medium (10% FBS, 1% antibiotics in DMEM-Ham’s F12 medium) and cells seeded on 10 
mm tissue culture plates (Fisher Scientific, Denmark) at a density of 5x103 cells/cm2. 
Medium was refreshed every three days and cells were passaged at 80% confluence 
following trypsin (Hyclone, Logan, UT) detachment and hemocytometer quantification. 
Standard culture conditions were used (5% CO2, 37◦C). 
3.2.4. CD105+, K14+ cell isolation  
Cells from fresh tissue were incubated with polyclonal antibodies, labeled CD105-PE (Mouse, 
eBioscience # 12-1057-42, San Diego, CA) and unlabeled K14 (Mouse, Fisher Scientific, # 
MA5-11599, Rockford, IL) to which a dylight 633 label (Fischer Scientific) was added, at a 
concentration of l μl (0.2 μg) /1x106 cells in darkness for 40 minutes. Cells expressing both 
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antibodies were selected with a FACSCalibur flow cytometer and Cell Quest Pro software 
(BD Biosciences, San Jose, CA).  
3.2.5. Cell cytoskeleton morphology  
Cells were added (5x103 cells/cm2) to 6-well culture plates (Fisher Scientific, Denmark) and 
cultured in stromal medium for 7 days. Following three rinses with PBS, cells were fixed in 4% 
paraformaldehyde at 4˚C overnight. Plates were rinsed with PBS and cells were 
permeabilized with 1% Triton-x100 for 20 minutes at room temperature followed by 
incubation with Actin-stainTM488 phalloidin (2 mg/ml, 1:150, # PHDG1-A, Cytoskeleton Inc., 
Denver, CO) according to the manufacturer’s instructions. Nuclei were stained with Hoechst 
33342 dye (10 mg/ml, 1:1000, # H1399, Invitrogen, Carlsbad, CA) and results were viewed 
with a fluorescent microscope (DM5000B, Leica, Buffalo Grove, IL) fitted with a digital 
camera (DFC 480, Leica).  
3.2.6. Transmission electron microscopy ultrastructure  
Megascopic cell pellets (3x106 cells) formed by centrifugation (260 ×g, 5 minutes) with cells 
detached as described above were fixed in 1.6% paraformaldehyde, 2.5% glutaraldehyde, and 
0.03% CaCl2 in 0.05M cacodylate buffer (pH 7.4) overnight. Following a 0.1M cacodylate 
buffer wash, post-fixation was performed with 2% osmium tetroxide for 1 hour, a distilled 
water wash, and incubation in 1% tannic acid for 1 hour. Cell dehydration was performed 
with propylene oxide in an ascending ethanol series followed with Epon-Araldite (EMS, 
Hatfield, PA) embedding. Blocks were sectioned (80-90 nm, Ultratome Leica EM UC7, 
Germany) and stained with 2% uranyl acetate in maleate buffer and lead citrate for 5 minutes. 
An electron microscope (JEOL JEM 1011, Japan) with a digital camera (Hamamatsu ORCA-




3.2.7. Transmission electron microscopy immunolabeling  
Pellets of K14+, CD105+ cells prepared as described above and cell constructs (described 
below) were fixed in 4% paraformaldehyde and 0.5% glutaraldehyde in 0.1M phosphate 
buffer (PB) for 10 minutes. Samples were centrifuged (260 ×g, 5 minutes), the supernatant 
removed and replaced with fresh fixative, and then samples maintained on an orbital shaker 
(Fisher Scientific, Canada) at room temperature for 2 hours. Following removal of the 
supernatant, pellets were combined with an equal volume of 3% agarose and cut into cubes 
following solidification. Cubes were placed into glass vials containing 0.1M phosphate 
buffer, pH 7.4, washed with 0.1M phosphate buffer and 0.08M glycine 5 times for 15 
minutes, and then washed with distilled water 3 times for 5 minutes.  
Samples were dehydrated in 100% ethanol 3 times for 20 minutes each. They were then 
infiltrated with 100% ethanol and London resin (LR) white (1:1) for 2 hours at room 
temperature followed by 2 hours of soaking in fresh 100% LR white. Samples were 
embedded in 100% LR white in a beam embedding capsule and polymerized at 65˚C for 24 
hours. Ultra-thin sections (90 nm, Leica EM UC7 Microtome) were collected on a 150-mesh 
filmed carbon coated nickel grid (EMS FCF-150-Ni). They were blocked with 5% bovine 
albumin (Sigma, St. Louis, MO) in PBS for 30 minutes, incubated with a K15 polyclonal 
antibody (rabbit, 0.2 mg/ml, 1:100, Proteintech, # 10137-1-AP, Rosemont, IL) in a buffer 
containing 1X phosphate buffered saline with tween 20 and 0.2% BSA-c (pH 7.4) for 4 hours 
at 4˚C, and then washed 6 times with buffer, each time 5 minutes. Sections were incubated 
with a gold conjugated secondary antibody (anti-rabbit IgG, 0.15 mg/ml, 1:20, 10 nm, 
Cytodiagnostics, # AC-100105, Canada) in buffer for 90 minutes at room temperature 
followed by a rinse with buffer as before. The same sections were incubated with a CD105 
antibody (mouse, 0.2 mg/ml, 1:10, eBioscience, # 12-1057-42, San Diego, CA) in buffer 
overnight at 4˚C. Sections were washed with buffer 6 times for 5 minutes, followed by 
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another wash in phosphate buffered saline with Tween 20 for 3 times, each time 5 minutes. 
They were then incubated with a gold conjugated secondary antibody (anti-mouse IgG, 0.15 
mg/ml, 1:20, 20nm, Cytodiagnostics, # AC-200205, Canada) in buffer for 120 minutes at 
room temperature followed by 6 buffer rinses, 5 minutes each. Samples were post-fixed in 
2% glutaraldehyde in PBS for 5 minutes. Sections were washed thoroughly in distilled water 
and stained with 2% uranyl acetate and lead citrate. Digital images were recorded as above.  
3.2.8. Stratum internum tissue decellularization  
Stratum internum tissue (5 x 5 x 5 mm) harvested as described above, was soaked in 0.1% 
EDTA in PBS at room temperature for one hour, then in PBS alone for another hour. Tissue 
was subsequently placed in 10mM tris (hydroxymethyl) aminomethane and 0.1% EDTA in 
distilled water overnight at 4˚C. Samples were transferred to PBS for one hour at room 
temperature and then to 10 mM tris (hydroxymethyl) aminomethane with 0.5% SDS in 
distilled water for 24 hours at 4˚C. They were washed with PBS three times for 5 minutes and 
then soaked in 4M ice-cold perchloric acid for 30 minutes. Samples were moved into PBS for 
1 hour and then lyophilized (-55˚C, VirTis BenchTop, Stanford, TX) for 12 hours. 
Lyophilized tissues were sterilized with ethylene oxide prior to addition of cells.  
3.2.9. Cell construct preparation and culture  
Cell pellets were prepared as described above and then resuspended in 200 μl of PBS. A total 
of 3x106 cells were added to stratum internum tissue scaffolds by pipetting to give a cell 
density of 2.4x104/mm3. Constructs were cultured in 12 well plates (Fisher Scientific, 
Denmark) with stromal medium for a total of 4 days under standard culture conditions (5% 
CO2, 37◦C). 
3.2.10. Construct ultrastructure with scanning electron microscopy (SEM)  
Representative samples from each construct were fixed with 2.5% glutaraldehyde in 0.1 M 
sodium carcodylate buffer (pH 7.4), post fixed in 0.1% osmium tetroxide, and dehydrated in 
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a series of ethanol-distilled water solutions. They were sputter coated with gold and imaged 
with an electron microscope (FEI Quanta 200, Netherlands) with a digital camera (Gatan 
Orius SC1000A1, UK).  
3.3. Results 
3.3.1. Cell cytoskeleton morphology  
Heterogeneous and CD105+, K14+ progenitor cell isolates had typical spindle shaped 
morphology with minimal cell clustering. Heterogenous cell isolates from inflamed tissue 
and isolates from cryopreserved, normal tissue had spindle-shaped morphology, but cells 
tended to aggregate in culture (Fig. 26). 
 
Figure 26. Passage 3 progenitor cells from fresh normal (A), inflamed (B), and cryopreserved 
normal tissue (C), as well as CD105+, K14+ cells from fresh normal tissue (D) with 
cytoskeletal (Actin-stainTM488, green) and nuclear (Hoechst dye, blue) staining.  
 
3.3.2. Transmission electron microscopy ultrastructure of unsorted normal cells 
There were distinct differences in ultrastructure among cell source environments. Progenitor 
cells from fresh normal tissue contained eccentric nuclei with typical euchromatin and 
closely approximated Golgi apparatus as well as abundant, cytoplasmic endosomes that were 
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often surrounded by mitochondria and rough endoplasmic reticulum (RER) (Fig. 27). Cell 
shape ranged from cuboidal to round with a relatively smooth surface. Cells contained 
multiple early and late endosomes, elongated mitochondria as well as large vacuoles. Early 
endosomes appeared as small, single compartment, membrane-bound vesicles. Late 
endosomes, also known as multivesicular bodies, had intraluminal vesicles, and tended to be 
larger than early endosomes. Vacuoles tended to be large and contents varied widely from 
vesicle remnants to proteinaceous and particulate material, sometimes within intraluminal 
vesicles and fused with early endosomes.  
 
Figure 27. Heterogeneous progenitor cell isolates from normal hooves. Cells typically 
contained a large eccentric nucleus (N) filled with euchromatin and surrounded by Golgi 
apparatus (white black arrow with G). Multiple, cytoplasmic, late (large black arrows with 
white outline) and early (small black arrows) endosomes were typically surrounded by 
normal (gray arrowhead) and elongated (gray arrows, white outline) mitochondria and RER. 
Abundant large vacuoles (V) had variable contents including particles (small white arrow 
with P) and intralumenal vesicles (small black arrow with I) and were sometimes fused with 





3.3.3. Transmission electron microscopy ultrastructure of unsorted cells from fresh 
inflamed tissue 
 
Cells from fresh inflamed hooves tended to be aggregated in thin sections similar to 
microstructural organization, and there were dead cells in various stages of degradation 
among viable cells (Fig. 28). The cell shape was comparable to that of cells from healthy 
tissue, but the surface was covered with shallow invaginations. Cells had large, irregular 
nuclei with large clefts in the nuclear envelope and contained lysosomes with darkly stained 
acidic content. Endosomes tended to be smaller and less abundant than those in cells from 
healthy tissue, clustered, and surrounded by mitochondria and irregular RER. Small coated 
vesicles were also around mitochondria. Large vacuoles were less frequent than in cells from 
healthy tissue. Mitochondria around vacuoles tended to be elongated.  
3.3.4. Transmission electron microscopy ultrastructure of unsorted cells from 
cryopreserved normal tissue 
 
Progenitor cells from cryopreserved normal tissue were characterized by dense, exocytic 
vesicles, and an irregular cell membrane covered with cytoplasmic protrusions and microvilli 
on the outer surface and endocytic vesicles on the inner surface. The cell cytoplasm was 
electron-dense and amorphous. Cell organelles consisted primarily of poorly organized RER, 
lysosomes with darkly stained material, small vacuoles with proteinaceous material, and 
endocytic vesicles. Large nuclei contained aggregated chromatin close to the nuclear 
membrane. Nonviable cells in various stages of degradation were present among viable cells 




Figure 28. Progenitor cells from inflamed (laminitic) equine hooves. Nonviable cells (large 
black arrows, white outline) were apparent among viable cells that had an irregular surface 
and large nuclei (N) with deep membrane clefts. Cells contained lysosomes (large white 
arrows, black outline) with dark staining acidic content. Vacuoles (V) and early endosomes 
(small white arrow) were less prevalent than in cells from normal tissues. Endosomes were 
surrounded by irregular RER and mitochondria (grayarrows, white outline). Small coated 
vesicles (white arrow head) were often present around mitochondria. Late endosomes that 
often contained single, large intralumenal vesicles (small black arrow) were also found 
around early endosomes. 
 
3.3.5. Transmission electron microscopy ultrastructure of unsorted cells from normal 
fresh tissue 
 
Cells from normal fresh tissue that were CD105+, K14+ were typically cuboidal and 
had infrequent microvilli on the cell surface (Fig. 30). Nuclei were large with euchromatin 
and prominent nucleoli. Endosomes and vesicles were infrequent, but those present were 
surrounded by mitochondria and RER. Desmosomes were frequently present between cells. 
Cells contained multivesicular bodies as well as small coated vesicles from early endosomes 





Figure 29. Progenitor cells from cryopreserved normal laminar tissue. The irregular cell 
membrane was covered by cytoplasmic protrusions and microvilli (large black arrows) that 
were closely associated with endocytic vesicles (small black arrows with E) and exocytic 
vesicles (white arrowhead). Nonviable cells (black arrow head) were present among viable 
cells. Chromatin was aggregated on the nuclear envelop (large white arrows). Dark stained 
lysosomes (small white arrow), small vacuoles (small black arrows) containing proteinaceous 
material, and multivesicular bodies were present (gray arrows, white outline) and surrounded 
by abundant, poorly organized rough endoplasmic reticulum (white circle). 
 
3.3.6. Transmission electron microscopy immunolabeling (K15, CD105)  
Gold particle labeled secondary antibodies to K15 (10 nm) and CD105 (15 nm) localized 
singly or together in the cytoplasm of sorted cells (CD105+and K14+) and sometimes in close 
proximity to the cell membrane (Fig. 31). There was no labeling in cells exposed to 
secondary antibodies alone (Fig. 31D).  
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Figure 30. Double positive (CD105+, K14+) progenitor cells from normal equine hoof tissue. 
Cells had a large nucleus (N), infrequent microvilli (large black arrow, white outline) on the 
surface, and sparse, large vacuoles (V). Multivesicular bodies (small black arrows) and 
endocytic vesicles (large white arrows, black outline) were present among mitochondria 
(gray arrow head) and RER. Desmosomes were present (small white arrows) between cells. 
Elongated mitochondria (gray arrows) and non-elongated mitochondria (gray arrow head) 
close to the nucleus were surrounded by small coated vesicles (white arrow heads).  
 
 
Figure 31. Gold-labeled secondary antibodies against K15 (10 nm) and CD105 (20 nm) in 
equine laminar progenitor cells from normal hooves sorted by co-expression of K14 and 
CD105 antigens. Gold labels (black arrows) localized throughout the cell cytoplasm (A, B) 
and in close proximity to the cell membrane (C), both singly and together. There was no 




3.3.7. Construct ultrastructure (no cell control) 
The primary and secondary epidermal lamellae structures were retained following 
decellularization, but they were devoid of extracellular matrix and cells (Fig. 32).  
 
Figure 32. Decellularized hoof stratum internum. The primary (black arrow, B) and 
secondary (white arrows, B, C) epidermal lamellae architecture was retained during the 
decellularization process, but it was devoid of extracellular matrix and cells.  
 
3.3.8. Construct ultrastructure (with cells) 
Cultured cells from fresh normal and laminitic tissue, from cryopreserved normal tissue, and 
K14+, CD105+ cells from fresh normal tissue attached to decellularized scaffold after 4 days 
of static culture in stromal medium (Fig. 33). There were abundant cells in all samples except 
those from cryopreserved tissues which were present in scarce clusters. The cells from 
laminitic tissue were also arranged in clusters, and cells from both had a round shape. Neither 
had detectable extracellular matrix around the cells. In contrast, cells from normal tissue were 
flattened and tightly adhered to the scaffold surface, and double positive cells were well 
adhered and embedded in early, fibrous extracellular matrix.  
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Figure 33. Scanning electrophotomicrographs of equine hoof progenitor cells on 
decellularized stratum internum tissue scaffolds after 4 days of static culture in stromal 
medium. Progenitor cells from normal tissue were strongly attached to the scaffold (A, E 
white arrows). Progenitor cells from inflamed tissue had a round shape and were present in 
clusters (B, F white arrows). Cells from cryopreserved tissue appeared in scarce clusters were 
round (C, G, white arrows). Double positive cells (K14+, CD105+) were well attached to the 
tissue scaffold (D, H white arrows) and surrounded by fibrous extracellular matrix (H, black 
arrow).  
 
3.3.9. Construct ultrastructure with transmission electron microscope double 
immunostaining 
 
Cell constructs with double positive sorted cells (CD105+and K14+) contained ectodermal 
and mesodermal protein antigens after 4 days of culture based on localization of gold labeled 
secondary antibodies K15 (10 nm) and CD105 (20 nm) in construct sections both together 
and separately (Fig. 34).  
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Figure 34. Construct sections demonstrating labeling of K15 (10 nm) and CD105 (20 nm) 
protein antigens in decellularized epidermal stratum interim following four days of culture 
with K14+, CD105+ hoof progenitor cells in stromal medium (A, B, black arrows). There was 
no labeling of decellularized tissue without cells (C, D).  
 
3.4. Discussion 
The results of this study clearly demonstrate important distinctions in progenitor cell 
morphology among normal, inflamed and cryopreserved equine hoof tissues and confirm 
unique structural characteristics of progenitor cells with both mesodermal and ectodermal 
antigens. This vital morphological information is invaluable to understanding the behavior 
and predicting the potential of adult progenitor cells harvested from the unique dermal-
epidermal interface in the equine hoof that shares many features with a similar tissue 
interface in the human fingernail plate and bed [275, 276]. Differences among progenitor 
cells provide important clues about tissue formation and maintenance by the cells in vivo, the 
de novo tissue forming potential of the cells in vitro, and the impact of cryopreservation and 
antigen-based sorting on the cells. The results of this study support that differences are 
maintained over multiple passages under optimal culture conditions and on 3-dimensional, 
 65 
tissue-based scaffolds. They also confirm that harvest tissue condition as well as post-harvest 
preservation and cell selection all significantly impact cell structure, a general reflection of 
function [277, 278]. 
The morphology of cells from fresh normal tissue, sorted (K14+, CD105+) and unsorted, were 
largely distinguished from each other by the presence of microvilli, fewer and smaller 
vacuoles, and more late endosomes dispersed throughout the cytoplasm in sorted cells. The 
presence of microvilli on the sorted cells may indicate greater commitment to intense 
exocytic and endocytic activity characteristic of higher plasticity [279]. Late endosomes are a 
sign of a high capacity for intracellular protein recycling required for successful 
differentiation in umbilical cord blood-derived multi-lineage progenitor cells [280]. 
Numerous vacuoles, thought to originate from dilated endoplasmic reticulum, in the 
heterogeneous cell isolates also indicate cytoplasmic endo- and exocytotic activities as 
documented in equine progenitor cells from other tissues [115, 223]. In both, the 
ultrastructural appearance was consistent with healthy progenitor cells from equine hoof 
tissue. 
Cell sorting facilitates isolation of homogeneous cell populations that are reported to have 
more predictable in vivo and in vitro behavior [281, 282]. The K14+,CD105+ subset of the 
heterogeneous progenitor cells from normal hooves may have greater capacity for 
differentiation into either ectodermal or mesodermal tissue [283]. This is suggested by the 
presence of microvilli resembling filopodia, a characteristic of cells capable of epidermal to 
mesodermal transition (EMT). An EMT cell signaling pathway, Wnt, has been identified in 
hoof tissue [67, 284]. Notably, immunostaining further confirmed that the cells continued to 
express antigens from both tissue lineages under standard culture conditions designed to 
maintain a progenitor cell morphology in this study. Hence, the observed morphology is 
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maintained in culture. Future work is needed to confirm the superior plasticity and EMT 
potential of the sorted cells. 
The cells from cryopreserved tissue showed features consistent with apoptosis including 
degranulation of prevalent RER, aggregated chromatin, and an irregular cell membrane with 
abundant exocytic vesicles [224, 285]. These findings are consistent with established 
knowledge that cells are somewhat “aged” by thermally induced stasis and show signs of 
necrosis, as well as a lower isolation rate, lower colony recovery rate and lower 
reprogramming efficiency than those from fresh tissue [286-289]. Thus, though the cells were 
capable of some proliferation and passage, they were unlikely to have much de novo tissue 
forming capacity. Notably, the cells were maintained at a low temperature consistent with 
short term preservation versus ultralow temperature for long term storage. As such, the 
results are specific to the conditions tested. It is possible that customization of 
cryopreservation techniques for protection of cells within tissues, isolation and preservation 
of cells separately from tissue, or maintenance of the cells in the vapor phase of liquid 
nitrogen may have less or different effects on the cells. 
Another important finding in this study were differences in progenitor cells from normal and 
inflamed tissues. The presence of lysosomes and degraded dead cells among cell isolates 
from inflamed tissue suggest that the cells were functioning more in tissue breakdown than 
production and maintenance [290]. The presence of cytokines, chemokines, and matrix 
metalloproteinase in inflamed hooves likely influences progenitor cell behavior and reduces 
plasticity of the cells  [68, 291, 292], in part due to direct damage to the cells themselves [293, 
294]. It is also thought that progenitor cells assume the characteristics of their environment 
[295]. This finding is especially important in light of the fact that the cells had some 
proinflammatory or catabolic morphology including lysosomes, irregular RER, and few 
cytoplasmic vacuoles, though they were continuously cultured under optimum conditions 
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following harvest. This is in contrast to some reports that cells recover in an ideal 
environment [296]. Targeted work is necessary to align actual cell behavior with the 
morphologies observed in this study.  
Many of the features of 2-D culture observed in this investigation were maintained in in 3-D 
culture, validating the 2D findings. It is especially important to note that, while cells from the 
heterogenous and sorted cohorts attached to the scaffold, only the K14+,CD105+ cells 
produced detectable ECM in a relatively short period of time. This further confirms the 
greater plasticity and neotissue forming capacity of the sorted cell population conveyed by 
the morphology. Cells from inflamed and cryopreserved tissue did not attach well, consistent 
with the apoptotic and catabolic appearance, respectively, observed in 2-D. Decellularized 
tissue scaffolds have advantages over synthetic biomimetic scaffolds, and they may be the 
best option for the unique equine hoof tissue interface [297, 298]. Notably, the K14+, CD105+ 
cells produced ectodermal and mesodermal proteins on scaffold constructs. This is promising 
for translation to clinical application because implantation of progenitor cell-scaffold 
constructs with well-integrated, functional cells have the best outcomes for normal tissue 
formation in vivo [241, 243].  
This study is limited by a single focus on cell ultrastructure. Prediction of cell behavior based 
on ultrastructural morphology is well documented [299, 300]. Additionally, the cell behaviors 
in 2-D culture were recapitulated in a 3-D environment. As noted above, additional side-by-
side comparisons of cell behaviors are required. Nonetheless, this novel work establishes a 
reproducible baseline on which to design future studies surrounding equine hoof progenitor 
cells.  
A major attribute of this study is the direct comparison of the ultrastructure of progenitor 
cells from multiple pre- and post-harvest conditions that clearly demonstrates important 
differences among them. Taken together, the new information reveals that progenitor cells 
 68 
from the equine hoof stratum internum have characteristics of undifferentiated cells with 
variable metabolic and synthetic capabilities determined by preharvest tissue conditions and 
postharvest cryopreservation or sorting. The ultrastructural morphology information in this 
study contributes to understanding of equine hoof progenitor cells to predict their potential 










































CHAPTER 4. EQUINE HOOF K14+CD105+PROGENITOR CELLS: A 





Background: Epithelial to mesenchymal transition (EMT), typically considered a pathologic 
neoplastic mechanism, is a normal process in epithelial tissue healing. Progenitor cells that 
reside in ectodermal-dermal junctions like the equine hoof stratum internum, may have 
enhanced multilineage differentiation capabilities and undergo EMT as part of normal tissue 
interface homeostasis. However, current evidence suggests that inflammatory cytokines may 
drive abnormal EMT and result in unbalanced tissue formation that contributes to fibrous 
tissue production and disruption of the ectodermal-dermal junction.  
Methods: Laminar tissue harvested from equine hooves (n=22, 11 unaffected, 11 laminitic) 
was harvested for three purposes: collagenase digestion for primary progenitor cell isolation; 
decellularization for tissue matrix; or cryosectioning for double (K14, CD105) 
immunohistochemical labeling. Viable K14+CD105+ cells were sorted from P1 
heterogeneous cell isolates. Paired evaluations of P3 heterogenous cell isolates and 
K14+CD105+ cells included gene expression (E-cadherin, N-cadherin, p63, K1, K10, CD44, 
CD105, β-catenin, transforming growth factor (TGF)-β1, -2, and -3) and antigen expression 
(E-cadherin, N-cadherin) with qRT-PCR and flow cytometry, respectively. Cryopreserved P3 
K14+CD105+ cells were cultured in stromal medium alone, stromal medium with 
interleukins (IL) 2 and 6 or on decellularized laminar matrix in stromal medium for 21 days. 
Total protein was extracted from cells cultured in stromal medium with and without ILs. 
Proteins were separated by SDS-PAGE and 130 kD as well as 26kD bands were analyzed 
with mass spectrometry. TGF- β1 protein expressed by cells were analyzed by ELISA. 
Ectodermal (K1, K10, p63) and β-catenin, TGF-β1, -2, and -3 gene expression and 
ectodermal (E-cadherin, K14) cell surface antigen expression was compared among culture 
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conditions. Cell-tissue construct microstructure was evaluated with light microscopy 
(Masson’s trichrome, H&E).  
Results: Double ectodermal (K14) and mesodermal (CD105) protein expression was 
confirmed both in vitro and in situ. Most equine hoof lamellatum progenitor cells are 
K14+CD105+. The cells have lower ectodermal (K1, K10, p63) gene expression compared to 
heterogeneous primary cell isolates, and EMT gene (E-cadherin, N-cadherin, β-catenin, 
CD44, CD105) expression was similar between them. Mesodermal gene (TGF-β1,2,3, β-
catenin, K1) expression was lower in K14+CD105+ cells cultured in stromal medium with 
inflammatory interleukins (2 and 6) than those in stromal medium alone. K14+CD105+ cells 
cultured with decellularized lamellar tissue matrix in stromal medium had higher p63, TGF-
β1 and E-cadherin gene expression as well as K14 surface antigen expression than those in 
stromal medium alone or with interleukins. Mass spectroscopy confirmed higher filamin A 
protein and heat shock protein β-1 expression by cells cultured with stromal medium with 
versus without interleukins.  Cell-lamellar tissue construct microstructure consisted of a 
single layer of closely aligned cells on the surface of secondary lamellae surrounded by 
poorly organized fibrous matrix.  
Conclusions: Majority of hoof primary progenitor cell isolates from equine hoof stratum 
internum express both ectodermal and mesodermal antigens and K15+CD105+ cell 
population has a higher percentage of EMT antigen expressing cells than primary progenitor 
cells. Inflammatory mediators support a propensity for EMT in hoof K14+CD105+ cells 
while normal matrix may inhibit this propensity.  
Ectoderm wound healing process, including skin healing process, is complex and 
incompletion or impairments in this process will lead a high level of morbidity and 
mortality[301]. Wound healing can be interfered with one or more phases like hemostasis, 
inflammation, proliferation or tissue remodeling[302]. Abnormal ectodermal scaring such as 
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keloid, is an impaired wound healing process characterized by abnormal keratinocytes 
proliferation and excessive deposition of extracellular matrix[303].   Current animal models 
for wounding healing such as rat, murine, and porcine, in which a hole will usually be created 
on the ectodermal area artificially and the wound closure rate will be determined later [304-
306]. However, the healing of an essential structure, epidermal-dermal interface, was not well 
studied in these animal models, but is presented well in equine hoof. In equine hoof, there is 
an unique epidermal-dermal tissue niche, in which the hoof stratum internum is composed of 
tightly-connected preliminary and secondary epidermal and dermal tissue but separated by 
basement membrane[6]. This structure can be damaged and regenerated during hoof growth 
or injury. Therefore, equine hoof will be a natural model for studying dermal-epidermal 
tissue repair.  
Epithelial to mesenchymal transition (EMT) is a biologic process during which 
polarized epithelial cells gradually transform into mesenchymal-like cells and loss their 
epithelial functionality and characteristics[307]. EMT is also a key biological process in 
tissue repair in which the cells around wound area will lose their intercellular adhesions and 
migrate across the wound to support new tissue generation[308]. Abnormal or partial 
epithelial to mesenchymal transition (EMT) in skin epithelial cells may lead a pathological 
fibroproliferative wound healing process, such as skin keloid, in which the skin keratinocytes 
exist EMT-related abnormalities and fail to express all the hallmarks of EMT[309]. 
Additionally, abnormal transforming growth factor (TGF)-β signaling pathway plays a key 
role in keloid pathogenesis and leads increased motility in keratinocytes and thus induce 
keloid formation[310]. Therefore, understanding abnormal cell EMT and TGF-β regulation in 
EMT will be essential for perusing cell-signaling-based therapies for ectodermal tissue 
healing.  
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Pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-a and interleukin 
(IL)1-β, together with TGF- β1 will accentuate EMT in epithelial cell lineages and promote 
dysregulated wound repair and was confirmed in human skin [311]. EMT signals like Wnt 
signaling pathway were confirmed in epithelail basal epithelial cells in laminitis, a process 
with multiple inflammatory cytokines and interleukins production, such as interleukin β, 
interleukin 2, interleukin 6, tumor necrosis factor α, and interferon gamma [60, 67, 312-314]. 
These inflammatory cytokines as well as interleukins seem to lead abnormal EMT signaling 
in laminar epithelial cell lineage and therefore cause laminar epithelial cell apoptosis, basal 
cell cytoskeleton collapse, and laminar tissue fibrosis[32, 66, 67, 315, 316]. In addition, 
inflammatory cytokines play a central role in laminar inflammatory responses regarding 
leucocyte emigration, metabolic and vascular alterations in laminitis[210]. These 
inflammation responses and alterations may further induce EMT followed with tissue fibrosis 
and tissue remodeling[317]. Thus, Information about the effects of inflammatory cytokines 
on laminar progenitor cells is both reasonable and vital for understating either tissue repair or 
maintenance with abnormal EMT signaling pathways.  
Either abnormal extracellular matrix (ECM) or ECM remodeling is one of the major 
contributions to abnormal scarring. ECM degradation by matrix metalloproteinases and ECM 
remodeling by changing stable ECM components will lead hypertrophic, keloid, and scarless 
healings[318].  Normal tissue matrix is responsible for normal ordering of highly organized 
tissues and that interacts with the local cell populations. Three-dimensional matrix is 
indispensable for creating an entire cell microenvironment[319]. Cell-matrix interactions can 
direct cell alignment and migration as well as apply physical signals. Decellularized tissue or 
organ, as a scaffold for tissue repair, has been investigated a lot recently for the advantages of 
providing normal tissue matrix that are necessary for cell proliferation[139]. Autograft or 
allograft transplantation used to be the main method for tissue regeneration, however, 
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problems such as high cost, limited available tissue and risks of rejection still exist for 
autograft and allograft transplantation[320, 321]. Decellularized rat esophagus was reported 
to have suitable compatibility for esophageal epithelial cell proliferation and keratinization by 
showing normal esophagus cell layers formation and specific esophagus keratin protein 
(keratin 34βE12) expression[322]. In equine, however, the optimal protocol for 
decellularization of hoof laminar tissue is extremely limited. In this study, we investigate the 
effect of normal tissue matrix from decellularized hoof laminar tissue on invitro 
characteristics of K14+CD105+ laminar progenitor cells.  
By using equine hoof as a novel epidermal-dermal wound healing model, we 
investigated EMT cell signaling pathways under normal and pathological culture condition. 
The two-part hypothesis tested was that K14+CD105+ equine hoof progenitor cells have 
higher EMT potential than heterogeneous cell isolates and that inflammatory cytokines 
promotes while decellularized normal tissue matrix inhibits EMT in K14+CD105+ cells. 
More importantly, we isolated a specific hoof progenitor cell population that express both 
ectodermal (K14) and mesodermal (CD105) antigens. Those K14+CD105+ progenitor cells 
have great potential to undergoing EMT pathway and help with laminar tissue epidermal-
dermal junction regeneration after damage. Overall, this unique and vital animal model with 
epidermal-dermal junctions will provide a novel insight in investigating EMT pathway, tissue 
repair and ectodermal tissue generation therapies.  
4.2. Materials and methods 
 
4.2.1. Study design 
Stratum internum tissue of 11 unaffected (U) and 11 laminitic (L) equine forelimb hooves 
was collected after humane euthanasia for reasons unrelated to this study (Table 1). Tissue 
was decellularized (n=5, U), evaluated with immunohistochemistry (n=3, U; n=2, L) for 
colocalization of keratin (K) 14 and cluster of differentiation (CD) 105, or processed for 
 74 
progenitor cell isolation by collagenase digestion. H&E and trichrome Masson staining was 
processed and analyzed by light microscopy (n=2, U). Cell outcome measures included 
passage (P) 3 K14+CD105+ cell isolation (n=11, U; n=11, L) from passage (P) 2 
heterogeneous cell isolates, double staining immunocytochemistry with P3 K14+CD105+ 
cells (n=2, U), gene expression of P3 heterogeneous cell isolates and K14+CD105+ cells for 
CD44, CD105, E-cadherin, N-cadherin, β-catenin, K1, K10, p63, TGF-β1,2,3 (n=5, U), cell 
surface antigen expression of P3 heterogeneous cell isolates and P3 K14+CD105+ cells for 
E-cadherin and N-cadherin (n=5, U), gene expression of P3 K14+CD105+ cells with and 
without treatments for K1, K10, p63, β-catenin, TGF- β1,2,3, cell surface antigen expression 
of P3 K14+CD105+ cells with and without treatments for E-cadherin and K14 (n=5, U), 
protein expression of P3 K14+CD105+ cells with and without treatments by ELISA (n=5, U), 
protein expression of P3 K14+CD105+ cells with and without treatments by mass 
spectrometry (n=2, U).  
4.2.2. Stratum internum collection 
 
Twenty-two horses were euthanatized for reasons unrelated to this study. Fresh hooves from 
both unaffected horses (n=11) and those with laminitis (n=11) were collected right after the 
euthanasia. Tissue was collected as previously described[323]. Briefly, each hoof was 
cleansed with 10% blench and 0.1% chlorhexidine before tissue collection. Stratum internum 
was exposed by using a reciprocating saw with sterile blades. Tissue was extracted and 
cleansed with 70% ethanol and phosphate buffer saline (PBS, Hyclone, Logan, UT) with 1% 






Table 5. Horse Information and Involved Assays II 
Age  
(year)     





















7 Unaffected                              Gelding Thoroughbred       X X X X  
5 Unaffected Gelding Thoroughbred       X X X X  
4 Unaffected Mare Quarter Horse       X X X X  
13 Unaffected Mare Thoroughbred  X        X X (X)   
7 Unaffected Mare Thoroughbred X         X (X)  X X 
8 Unaffected Mare Quarter Horse       X  X X  
16 Unaffected Mare Thoroughbred X  X X (X) (X)  
12 Unaffected Mare Thoroughbred X  X (X) (X) (X) (X) 
18 Unaffected Mare Quarter Horse (X)  X (X) (X) (X)  
8 Unaffected Gelding Thoroughbred (X) X X (X) X (X) (X) 
27 Unaffected Gelding Quarter Horse   X (X) (X) (X) X 
20 Laminitic Mare Thoroughbred   X  X X  
4 Laminitic Gelding Quarter Horse   X X X X  
18 Laminitic Mare Thoroughbred   X X X   
9 Laminitic Gelding Thoroughbred   X X X X  
18 Laminitic Mare Paint   X X  X  
16 Laminitic Mare Thoroughbred   X X (X) X  
7 Laminitic Mare Quarter Horse X  X (X) (X) (X)  
9 Laminitic Mare Quarter Horse   X (X) X (X)  
14 Laminitic Mare Quarter Horse   X (X) (X) (X)  
19 Laminitic Mare  Quarter Horse X  X (X) (X) (X)  
12 Laminitic Gelding Quarter Horse   X (X) (X) (X)  
 
4.2.3. Heterogeneous primary cell isolation and expansion 
 
Primary progenitor cells were isolated as previously described [323]. Stratum internum tissue 
was minced well on a sterile petri dish (NuncTM IVF petri dish, Thermo Fisher Scientific, 
Waltham, MA) and then digested with 1% bovine serum albumin (BSA, Sigma Aldrich, St. 
Louis, MO), 0.1% type-1 collagenase (Worthington Biochemical Corporation, Lakewood, NJ) 
in dulbecco’s modified eagle’s medium with Ham’s F12 nutrient mixture (DMEM-Ham’s 
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F12, Hyclone). Digestion process was processed at 37 ˚C and last for 2 hours with 3-
dimentional agitation (5.5×g, GyroTwister™ GX-1000, Labnet, Inc., Edison, NJ). The 
digestion mixture was then filtered with both 100 µm and 70 µm filter (Thermo Fisher 
Scientific, China) respectively and centrifuged for 5 minutes at 250×g to get stromal vascular 
fraction pellets. The SVF pellets were then resuspended in stromal culture medium (1% 
antibiotic antimycotic solution (MP biomedical), and 10% characterized fetal bovine serum 
(VWR Life Science, Radnor, PA) in DMEM-Ham’s F12 medium) and seeded on culture 
plate (Thermo Fisher Scientific, Rochester, NY) at a density of 5x103 cells/cm2 under 
standard culture condition (37 ˚C, 5% CO2). Medium was refreshed after the first 12 hours 
and then every 2 days until 80% cell confluence. Cells were then passaged up to passage 2.  
4.2.4. Immunohistochemistry 
 
Laminar tissue was embedded in optimal cutting temperature (OCT, Sakura Finetek Inc., 
Torrance, CA) medium and solidified at -80°C, then sectioned with a cryostat (Leica® 
CM1850, Sarasota, FL) and applied to slides. Sections were blocked with 10% of goat serum 
(Gibco® 1788320, grand island, NY) for 2 hours at room temperature. Slides were then 
incubated with K14 (Mouse, 2ug/ml, Fisher Scientific, # MA5-11599, Rockford, IL) and 
CD105 (Rabbit, 0.2mg/ml, PA5-16895, Invitrogen, Rockford, IL) primary antibodies for 
overnight at 4 ˚C and rinsed with TBS containing 0.025% triton for 5 times followed with 2 
hours of labeled secondary antibodies (IgG-488, Donkey, 2mg/ml, 1975519; IgG-594, 
Chicken, 2mg/ml, 19179547, ThermoFisher, Eugene, Oregon) incubation avoid from light. 
Slides were rinsed with TBS for 3 times and then nuclei were stained with DAPI for 10 
minutes at room temperature in darkness. Unstained tissue and sections incubated with 
secondary antibody alone were incubated as control samples. Digital images were collected 
with a fluorescent microscope (DM 4500b, Leica) equipped with a digital microscope (DFC 
480, Leica).   
 77 
4.2.5. K14+CD105+ progenitor cell isolation 
 
Cells were incubated with CD105-PE (Mouse, eBioscience # 12-1057-42, San Diego, CA), 
K14 (Mouse, Fisher Scientific, # MA5-11599, Rockford, IL) antibodies (0.2 μg /ml) that 
were already conjugated with PE and dylight 633 (53046, ThermoFisher, Rockford, IL) 
respectively (l μl /1x106 cells) for 45 minutes in dark. Then cells were analyzed and sorted 
with a FACSCalibur flow cytometer and Cell Quest Pro software (BD Biosciences, San Jose, 
CA). K14+CD105+ progenitor cells were collected and cultured with the stromal culture 
medium mentioned previously.  
4.2.6. Immunocytochemistry 
 
K14+CD105+ progenitor cells were seeded (5x103 cells/cm2) on a six-well culture plate 
(Fisher Scientific, Denmark) and cultured until 80% of confluent. Cells were then washed 
three times with PBS and fixed with 4% of paraformaldehyde overnight at 4 ˚C. Following 
three times of wash with PBS, cells were permeabilized with 0.5% Triton-x100 for 20 
minutes and blocked with 10% of goat serum (Gibco®, Grand Island, NY) for 1 hour at room 
temperature. Cells were cultured with CD105 (Rabbit, 0.2mg/ml, # TG2603391C, Invitrogen, 
Rockford, IL) and K14 (Mouse, 0.2 mg/ml, Thermo Fisher Scientific, Rockford, IL) primary 
antibody for 2 hours at 37 ˚C. Then cultured with Alexa Fluor 594 chicken anti-rabbit IgG 
(0.2 mg/ml, # 1917947, Thermo Fisher Scientifc, Eugene, Oregon) and Alexa Fluor 488 
donkey anti-mouse IgG (# 1975519, Thermo Fisher Scientific) secondary antibodies for 1 
hour at 37 ˚C in darkness. Nuclei were stained with 4, 6-diamidoino-2-phenylindole (DAPI) 
for 10 minutes in darkness. Photomicrographs were analyzed with a fluorescent microscope 
(DM 4500b, Leica) equipped with a digital camera (DFC 480, Leica).  
4.2.7. Mass spectrometry 
Protein samples were separated by running sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) assays. Gels were then stained with 0.5% Coomassie blue and 
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gel bands around 130KD and 26KD were excised. Gel bands were destained with 50% of 
acetonitrile and 50mM ammonium bicarbonate solution. Sequence grade, modified bovine or 
porcine trypsin (Sigma Aldrich, 12.5ng/ml) was used for in-gel digestion. Digestion was 
processed at 37 oC overnight and stopped by adding 10% formic acid solution. Peptides were 
extracted with 50% of acetonitrile and 50mM ammonium bicarbonate solution followed with 
another extraction with 100% of acetonitrile. Extracted peptides were then concentrated and 
dried for spectrometric analysis with an AmaZon speed ETD Ion Trap mass spectrometer 
(Bruker Daltonics, Billerica, MA, USA). Mass detection was performed in full-scan mode in 
positive ionization enhanced resolution mode with the scan speed of 8100 m/z/s. The 
software used for data processing and de-convolution was Compass DataAnalysis (Bruker 
Daltonics). Identification of the proteins was accomplished on the basis of the NCBIprot 
database using the MASCOT search program (Matrix Science, London, UK) from the 
peptides generated from the digest. A mass deviation of < 0.2 Da and one missed cleavage 
were allowed in the database searches. 
4.2.8. Enzyme linked immunosorbent assay (ELISA)-TGF- β1 
A commercially available equine TGF-β1 kit (Genorise Scientific, Glen Mills, PA) was used. 
A seven-point standard curve was generated using 2-fold serial dilutions with TGF-β1 
standard. Cell culture medium samples were activated with 1 N HCI for 10 minutes and 
neutralized with neutralization buffer before use. Samples and standard were vortexed well 
before adding to the antibody-coated 96-well plate, the plate was then covered and incubated 
1.5 hour at room temperature. Then each well was aspirated and washed with assay buffer for 
3 times followed with another one-hour culture with detection antibody at room temperature. 
After 3 times of washing with assay buffer, HRP conjugate was added to each well and 
incubated for 20 minutes avoid from light. Then each well was washed with assay buffer for 
3 times and incubated with substrate solution for 20 minutes avoid from light. Finally stop 
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solution was added to each well and the plate was gently tapped to ensure thorough mixing. 
TGF- β1 protein concentration was quantified by absorption at 450nm and a wavelength 
correction was set at 540nm.  
4.2.9. Target gene expression (qRT-PCR) 
 
Equine specific primers were designed for CD44, CD105, K1, K10, p63, E-cadherin, N-
cadherin, TGF- β1, TGF- β2, TGF- β3, and β-catenin. Total mRNA was extracted from P3 
heterogeneous cell isolates and K14+CD105+ progenitor cells with a mRNA isolation kit 
(RNAqueous Micro Kit, Ambion, Inc., Austin, TX), and NanoDrop technique (Montchanin, 
DE, USA) was used to determine the concentration. Then cDNA was generated with a 
quantiTect reverse transcription kit (Qiagen, GmbH, Germany). Target gene mRNA levels 
were quantified with qRT-PCR using SYBR green technology (Qiagen) and an mJ research 
chromo4 detector (Bio-rad laboratories, Herules, CA). The ΔCt values were determined 
relative to the reference gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
Table 6. Primer Sequences Information for K14+CD105+ and Heterogeneous Equine Hoof 
Progenitor Cells 
 
Gene Forward  Reverse  Accession No. 












P63 ATCAACCCTCAGCAGCG ATGAACAGCCCAACCTCG XM_023623496 












TGF β1 AGCCTGAGGCGGACTACT  GCCGGTCTCCACAGTCTTAT XM_005596086  
TGF β2 ATGCCAACTTCTGTGCTGGA ACACACAGCAAGGAGAAGCA XM_005608026 
TGF β3 TGGAACCAACCTGTTCCGAG GCGTTGTTTGGCGATATGCT XM_001492687 
CD44 GTGTGGACAGAAGAAGAAGCT CAATCTTCATGTCCACATTCTGC XM_023653788 
CD105 GACGCCAATCACAACATACA TCCACATAGGACGCTACGAC XM_003364144 
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4.2.10. Flow cytometry 
 
Cell aliquots (106 cells) were suspended in 800ul of 1% BSA containing 0.2% of sodium 
azide. Monoclonal labeled antibodies E-cadherin-488 (Rat, 0.5 mg/ml, 53-3249-82, 
ThermoFisher, Carlsbad, CA), N-cadherin-PE (Mouse, 50mg/ml, 12-3259-42, ThermoFisher, 
Carlsbad, CA), K14 (Mouse, Fisher Scientific, # MA5-11599, Rockford, IL) with a dylight 
633 label (Fischer Scientific) were added to the cell suspension and incubated for 45 minutes 
at 4 degree avoid from light. Cells were then washed and resuspend with PBS.  Cells were 
not incubated with antibodies were used as autofluorescence control. Cell fluorescence was 
analyzed with a FACSCalibur flow cytometer and Cell Quest Pro software (BD Biosciences, 
San Jose, CA).  
4.2.11. Stratum internum tissue decellularization and cell construct culture 
Stratum internum tissue (5 x 5 x 5 mm) was decellularized with 0.1% EDTA and 0.5% SDS 
solution as previously described [324]. After decellularization, samples were moved into PBS 
for 1 hour and then lyophilized (-55˚C, VirTis BenchTop, Stanford, TX) for 12 hours. 
Lyophilized tissues were sterilized with ethylene oxide prior to addition of cells. Cell pellets 
were resuspended in 100 μl of stromal medium. A total of 3x106 cells were added to stratum 
internum tissue scaffolds by pipetting to give a cell density of 2.4x104/mm3. Constructs were 
cultured in 12 well plates (Fisher Scientific, Denmark) with stromal medium for a total of 21 
days under standard culture conditions (5% CO2, 37◦C) and medium was refreshed every 3 
days. 
4.2.12. Light microscopy 
Hematoxylin & eosin (HE) staining  
P3 K14+CD105+ progenitor cell and tissue constructs were embedded with paraffin and 
sectioned into slides. Then slides were deparaffinized with xylene and ethanol and followed 
with a deionized water wash. After that slides were stained with hematoxylin for 8 minutes 
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and then washed with tap water for 3 minutes. Then slides were stained with eosin-phloxine 
for 30 seconds followed with dehydration in 95% alcohol for 10 minutes. Finally, slides were 
clear in xylene for 5 minutes and mounted with xylene based mounting medium.  
4.2.13. Trichrome masson staining  
Cell and tissue constructs were embedded with paraffin and sectioned into slides. Slides were 
deparaffinized with mordant in Bouin’s solution for overnight. After washing with tap water, 
slides were stained with Weigert’s iron hematoxylin solution and Biebrich scarlet acid 
solution. Then slides were placed in phosphomolybdic acid solution, aniline blue solution and 
acetic acid solution for 5 minutes, respectively. Finally, slides were dehydrated with 95% 
alcohol and clear in xylene.  
4.2.14. Statistical analysis 
 
Statistical analyses were processed with commercially available software (SAS 9.2, Institute, 
Cary, NC). Analysis of variance (ANOVA) models were used to measure K14+CD105+ cell 
percentages within passages, surface antigen expression and multiple gene expression levels. 
Unpaired T-test models were used to measure cell surface marker expression, CD, and DT. 
Tukey’s post hoc tests were applied for multiple group comparisons (p<.05).  
4.3. Results 
 
4.3.1. Immunohistochemistry (K14, CD105) 
 
Double fluorescent immunohistochemistry labeling confirmed the presence of both K14 (Fig. 





Figure 35. Fluorescent photomicrographs of lamellae form unaffected hooves labeled with 
antibodies against K14 (A, B) and CD105 (D, E). Red and green fluorescence merge in 
yellow (C, F).   
 
4.3.2. Immunocytochemistry (K14, CD105) 
 
Fluorescent immunocytochemistry labeling confirmed the presence of both K14 (Fig. 36 A) 
and CD105 (Fig. 36 B) on P3 K14+CD105+ progenitor cells.  
 
Figure 36. Fluorescent photomicrographs of P3 cultured hoof K14+CD105+ progenitor cells. 
K14 (green, A), CD105 (red, B) protein expression were double detected at the same time 
and same place. Combined staining graph (yellow, C). Nuclei were stained with DAPI (blue, 
D). Bar = 100μm 
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4.3.3. K14+CD105+ progenitor cell percentages 
The percentage of single K14 positive cells was found higher in unaffected hooves and single 
CD105 positive cells were extremely low in both unaffected and laminitic hooves. Most cell 
populations in equine hoof are double positive cells (Fig. 37 A). K14+CD105+ progenitor 
cells were isolated from both unaffected and laminitic hooves up to passage 2 and occupied 
80% of the total cell composition (Fig. 37 B). From passage 0 to passage 2, the percentages 
of K14+CD105+ progenitor cells are lower in laminitic hooves than unaffected hooves with 
no significant differences among passages (Fig. 37 C).  
 
 
Figure 37. Percentages of single K14+ or CD105+ positive cells (A), double K14+CD105+ 
cells (B), and K14+CD105+ progenitor cells within cell passages 0-2 (C) in both unaffected 
and laminitic hooves (mean±SEM). Columns stand for K14+ cells are distinct from each 
other (P < .05). 
 
4.3.4. Flow cytometry-E-cadherin, N-cadherin 
 
P3 cultured progenitor cells and K14+CD105+ progenitor cells from unaffected hooves 
expressed both E-cadherin and N-cadherin. E-cadherin expression in unsorted cells and 
K14+CD105+ cells are 43.4 ± 3.9 and 68.0 ± 4.7 respectively. N-cadherin expression 
percentages in unsorted and K14+CD105+ cells are 22.5 ± 6.3 and 41.3 ± 7.8 respectively. E-
cadherin expression is significantly higher in K14+CD105+ progenitor cells compared to 
unsorted cells, and E-cadherin expression is significantly higher than N-cadherin expression 
in K14+CD105+ cells (Fig. 38). 
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Figure 38. Percentage (mean ± SEM) of E-cadherin+ (black) and N-cadherin+ (gray) 
K14+CD105+ progenitor cell and unsorted cells from unaffected hooves. Columns with 
different letters and columns with symbols are distinct from each other (P<.05).   
 
4.3.5. Target gene expression (qRT-PCR) 
 
Gene expression of K1, K10, p63 by P3 K14+CD105+ progenitor cell and unsorted 
heterogeneous cell isolated from unaffected hooves were conformed (Fig. 39 A). In addition, 
EMT gene includes CD44, CD105, β-catenin, E-cadherin, N-cadherin, and TGF-β1, -2, -3 
expression were found in both K14+CD105+ progenitor cell and unsorted heterogeneous cell 
isolates (Fig. 39 B). K1 expression is significantly higher in unsorted cells compared to 
K14+CD105+ cells. 
 
Figure 39. Expression levels (ΔCT, mean ± SEM) of K1, K10, p63 (A), CD44, CD105, β-
catenin, E-cadherin, N-cadherin, TGF- β1, -2, -3(B) in P3 K14+CD105+ progenitor cells and 
unsorted heterogeneous isolates from unaffected hooves. Reference gene: GAPDH.  Columns 





4.3.6. HE and trichrome masson staining  
 
H&E (Fig. 40 A, B, C) and Trichrome Masson staining (Fig. 40 D, E, F) confirmed cell 
attachment on decellularized laminar scaffold. In scaffold loaded with cells, the secondary 
epidermal laminae attached to the sides of the primary epidermal laminae tightly (Fig. 40, B, 
E) while in scaffold without loading cells, the secondary epidermal laminae did not attach to 
primary epidermal laminae (Fig. 40 C, F). Attached cells were closely aligned in a single 
layer along secondary lamellae and surrounded by some poorly organized fibrous matrix (Fig. 
40 B, E). Control group doesn’t show cell staining (Fig. 40 C, F).  
 
 
Figure 40. Light photomicrographs of lamellae stained with HE (A, B, C) and trichrome (D, 
E, F).  Cell nucleus were stained dark purple, matrix and cytoplasm were stained pink or red, 
collagen fibrils were stained blue.  
 
4.3.7. Surface antigen and gene expression in K14+CD105+ cells with different culture 
condition 
 
E-cadherin surface antigen expression (Figure 41 A) is significantly lower (20.9 ± 6.8) in 
cells cultured with IL medium compared to cells cultured with normal matrix (72.1 ± 1.7) and 
stromal medium (50.1 ± 4.9). Ectodermal gene (K1, p63) expression (Figure 41 B) is 
significantly lower in cells cultured with IL medium (ΔCT 8.8 ± 0.7, 12.9 ±0 .3) compare to 
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cells cultured with normal matrix (ΔCT 4.9±0.5, 8.8±0.4) and stromal medium (ΔCT 4.0 ± 
0.4, 10.6 ± 0.3). TGF-β1, -2, -3 and β-catenin gene expression (Figure 41 B) is significantly 
higher in cells cultured with stromal medium (ΔCT -1.5 ± 0.3, -6.1 ± 0.4, -4.3 ± 0.3, -
10.0±0.3) compared to cells cultured with IL medium (ΔCT 1.6 ± 0.3, -3.4 ± 0.4, -2.1 ± 0.7, -
6.4 ± 0.7). TGF-β1gene expression is significantly higher in cells cultured with matrix (ΔCT -
2.2 ± 0.2) compared to cells cultured with IL medium (ΔCT 1.6 ± 0.3). 
 
 
Figure 41. E-cadherin and K14 surface antigen (A) percentages (mean ± SEM) and gene 
expression (B) levels (ΔCT, mean ± SEM) of TGF- β1, -2, -3, β-catenin, K1, K10, and p63 
from P3 K14+CD105+ progenitor cells cultured with stromal medium, IL medium and 
normal matrix.  Reference gene: GAPDH. Columns with different letters are significantly 
different among treatments or gene (P < .05). 
 
4.3.8. Enzyme Linked Immunosorbent Assay (ELISA)-TGF-β1 
There is a significantly lower TGF- β1 protein expression in the culture medium of cells 
cultured with IL medium (214.6±30.4 pg/ml) compared to cells cultured with stromal 
medium (403.1±45.0pg/ml) (Figure 8, B). TGF- β1 protein expression is slightly higher in the 
culture medium of cells cultured with normal matrix (249.6±42.4 pg/ml) compared to cells 




Figure 42. The 7 points standard curve used to determine sample concentrations (A). Total 
TGF- β1 protein expression in the culture medium of cells cultured with stromal medium, IL 
medium and normal matrix (B). Columns with different letters are significantly different 
among treatments (P < .05). 
 
4.3.9. Mass spectrometry 
Results indicate that peptides from protein bands at 130kD and 26kD (Fig. 43) were 
significantly different between cells cultured with IL medium and stromal medium (Fig. 44). 
Protein expression of filamin A and heat shock protein (HSP)-β1 is significantly higher in 
cells cultured with IL medium compared to cells cultured with stromal medium (Fig. 44 E, F). 
 
 
Figure 43. Photograph of SDS-PAGE gel with protein bands (black). Size markers (1, 2) 
show a range between 10 kD and 170kD. Proteins were from cells cultured with IL medium 
(3, 4) and stromal medium (5, 6). Protein bands between 130kD and 170kD (long arrows) or 





Figure 44. Relative absorbance photograph of mass spectrometry analysis from protein 
peptides extracted from cells cultured with IL medium (A, C) and stromal medium (B, D). 
Mascot protein score (E, F) of filamin A and HSP-β1 protein, score greater than 94 was 





The results of this study clearly demonstrate the important effects of inflammatory 
interleukins and normal tissue matrix on equine hoof K14+CD105+ progenitor cells and 
confirm the EMT potential of both hoof heterogeneous and K14+CD105+ cell population. 
This vital in vitro progenitor cell behavior information is invaluable to understanding the 
behavior and predicting the EMT potential of hoof progenitor cells under either inflammatory 
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or normal culture condition. Laminitis is a multifactorial condition defined as inflammation 
of sensitive hoof tissues but also recognized pathologic changes with or without 
inflammatory mediators[325]. Information about equine hoof progenitor cell population and 
impact of inflammation as well as matrix on progenitor cells provides essential clues about 
cell signaling pathways in different cell populations under different culture condition, and 
abnormal tissue formation as well as normal tissue maintenance by cells in different 
microenvironments. 
Investigations of progenitor cells that have both dermal and ectodermal characteristics 
can provide guidance for dermal and ectodermal tissue engineering[326]. Current studies 
focus on investigating enzymes or molecules associated with epidermal-dermal junction 
membrane formation or perturbation[327-329],  but information about progenitor cells 
around epidermal-dermal junction that may help with interface protection or regeneration is 
largely limited. Only few studies mentioned stem cells around dental pulp membrane 
junction[330]. Epidermal-dermal junction is a function unit involved with epidermal-dermal 
adherence, integrity and epidermis mechanical support. It is a membrane associate complex 
in maintaining the stable link between basal epithelial cells and dermis[331, 332]. Usually it 
is connected with epidermis basal cell layers, basal cell membrane and regular-distributed 
filamentous structures[333]. Epidermal cells were found to migrate through dermal-
epidermal interface in wound healing process [334-337]. In equine hoof, laminar dermal and 
epidermal connection dysadhesion or degradation is a common pathological condition in 
equine laminitis[110]. This process is associated with the loss of type IV, VII collagen, 
laminin, and activation of matrix metalloproteinases[338-340]. Downregulation of 
desmosomal proteins or hemidesmosomes is another reason for the failure of hoof dermal-
epidermal attachment[53, 341].  
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Cell fate is not always deterministic and there is an intermediate (transitional) cell state from 
which the cells can be converted through reprograming [342, 343]. The history of changing 
cell history began in 1990s, when cell oocyte-mediated nuclear transfer reprogramming was 
firstly introduced [344]. After that ectopic transcription factors were found to induce 
transdifferentiation and produce induced pluripotent stem cells (iPSCs) from adult somatic 
cells [345].  However, nuclear transfer reprogramming faced a number of ethical issues 
because nuclear transfer embryonic stem cells have been generated using human cells and 
therefore has very limited clinical applications [346]. Transcription factor-based cell 
reprograming also show drawbacks because the insertion of vectors in reprogramming 
process may cause unintended outcomes [347]. Recently, studies are focusing on chemical 
reprogramming, from which some chemical molecules were used for iPSCs [342]. Chemical 
reprogramming usually needs a long period to get iPSCs but is a much safer way than the 
previous two reprogramming techniques [348, 349]. In this study, we also found an 
intermediate cell population from equine hoof tissue, K14+CD105+ progenitor cells, and 
their cell fate can be converted with chemical reprogramming assay. Taken together, results 
in this study provide novel information on equine hoof cell population and potential 
progenitor cell based therapeutic strategies to restore hoof tissue.  
Epithelial to mesenchymal transition (EMT) is an established mechanism by which the 
epithelial cells lose their epithelial characteristics and become migratory mesenchymal cell 
lineage [350].  Notably, EMT process includes disruption of cell to cell junctions and 
increased inflammatory cytokine expression, similar to consequences of equine laminitis [351, 
352]. Therefore, expression of EMT markers in this study indicating EMT pathway may be 
one of the critical cell-signaling pathways happens in laminitis. In addition, the EMT 
pathway may explain the situation that cells cannot fully keratinized in hooves with laminitis. 
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By inhibiting EMT signaling pathway in hoof cells, the laminitis symptoms could be reduced 
at some degree.  
Inflammation factors are essential clinical signals for transplantation or tissue regeneration 
therapies and were associated with alloimmune and no-alloimmune epithelial injuries. 
Inflammatory cytokines or pre-inflammatory cytokines were found to accentuate EMT and 
dysregulate airway epithelial repair in human[311]. In our study, the results also indicate 
inflammatory interleukins promote EMT proteins and gene expression in equine hoof 
progenitor cells. Therefore, by stopping the inflammation process of hoof injuries may inhibit 
EMT in hoof cells and consistent abnormal hoof tissue formation. This may explain the use 
of anti-inflammatory drugs in equine laminitis treatments[353]. However, the concentration 
of inflammatory cytokines in injured hooves is variable and unknown in most cases, our 
study only investigated the effect of one concentration of inflammatory cytokines on hoof 
progenitor cells, which is one limitation of the study. Therefore, future studies should detect 
several inflammatory cytokine concentrations and document the possible different outcomes 
from each concentration. 
Taken together, our results confirm that the majority of progenitor cell isolates from the 
equine hoof epidermal-dermal interface express both ectodermal and mesodermal antigens 
and that the K14+CD105+ cell population has a higher percentage of EMT surface antigen 
expressing cells than heterogeneous primary cells. This suggests that cell plasticity required 
to maintain both the interface and two tissue types may be enhanced by EMT capabilities. 
The most relevant gene expression results confirmed the lowest mesodermal gene expression 
in cells cultured with versus without matrix, supporting the hypothesis. Protein expression, 
however, strongly supports the ability of the cells to assume either ectodermal or mesodermal 
phenotypes and that inflammatory mediators may support a propensity for EMT. This study 
creates a unique and valuable invitro model for study of equine hoof progenitor cell EMT to 
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design preventative and restorative therapies for equine laminitis or other equine hoof injuries 








































CHAPTER 5. SUMMARY AND FUTURE STUDIES  
 
The focus of this dissertation is to isolate, identify and characterize a progenitor cell 
from equine hoof stratum internum, varying pre- and post-harvest conditions.  In the past 
decades, equine hoof studies mainly include investigations about hoof structure, hoof growth, 
hoof physiology, hoof diseases, hoof mechanical testing, and shoeing. There is relatively 
limited information about hoof progenitor cells and progenitor cell behaviors, which is 
critical for understanding hoof organization and regeneration. Only a few studies report about 
hoof basal cells and epithelial cells in vivo as well as using mesenchymal stem cells to treat 
laminitis.  Therefore, more information is necessary to contribute to the understanding of 
equine hoof progenitor cells from multiple harvest conditions in tissue maintenance, damage, 
regeneration as well as post-implantation behaviors. Hoof progenitor cells show similar in 
vitro characteristics relative to other reported progenitor cells, but in vitro behaviors will 
change in response to other factors, such as cryopreservation, inflammatory interleukins, and 
tissue matrix.  This dissertation describes creation of an in vitro model for characterizations 
of equine hoof progenitor cells at genetic, protein and ultrastructural levels.  This information 
can be used to inform future therapeutic treatment of equine laminitis, improving prognosis 
through cell-based implantation.  
We illustrated how to isolate progenitor cells in the second chapter of this dissertation 
with a documented protocol in our laboratory. We found the enzyme digestion outcomes may 
be varied in different tissue and species. The enzyme concentration and digestion time are 
closely correlated with a cell survival rate as well as the final cell yield.  In this study, we 
only chose one proper enzyme concentration and digestion time for equine hoof progenitor 
cell isolation, which is not enough for getting the best outcomes of hoof progenitor cell 
isolation. With different isolation conditions, equine hoof progenitor cells may behave 
similarly or significantly differently in vitro. Thus, our information provides important 
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information for future studies on investigating proper enzyme concentration levels and 
digestion times to get the robust cell population.   
Based on the gene and protein expression data from the second chapter of this 
dissertation, we concluded that progenitor cells isolated from equine laminar tissue are not 
homogeneous. Those heterogeneous cell populations show both ectodermal and dermal 
protein and gene expressions but the expressions are variable among samples. Currently, we 
cannot know the exact stage of laminitis for every tissue sample we got, so we do not know if 
different pathological conditions of the tissue sample would affect the characteristics of 
progenitor cells isolated from. This could be one reason to explain the variations among 
different samples. Therefore, in the third and fourth chapters, we discussed how to sort the 
heterogeneous cell population to get a more homogeneous and consistent cell population, the 
K14+CD105+ cell population. K14+CD105+ progenitor cells show strong in vitro 
proliferation and consistent ectodermal and dermal gene as well as protein expression. EMT 
antigen and gene expression was more consistent in K14+CD105+ cells compared to 
heterogenous cell population. This novel cell population provides further evidence for the 
existence of EMT in equine hoof and therefore showing the therapeutic potential of using 
K14+CD105+ cells in treatments.  
Based on our data in chapter two and three, we know that gene and protein expression 
in both normal and laminitic groups are not significantly different, but cell morphology is 
distinct among different harvest conditions. The reason could be that we cultured cells from 
normal and laminitic hooves in the same culture condition that is ideal for cell growth and 
proliferation. Therefore, those hoof progenitor cells will finally show similar phenotypes after 
several passages. But ultrastructure results still indicate the different characteristics of 
progenitor cells from different harvest conditions. We also pointed out the significant effects 
of cryopreservation on hoof progenitor cells. Next, to mimic the inflammatory growth 
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condition in the real laminitic hoof, we added interleukins factors into culture medium and 
found inflammatory interleukins do affect the in vitro behaviors of hoof progenitors. 
Progenitor cells cultured with inflammatory interleukins express lower levels of ectodermal 
genes, surface antigens and proteins compared to cells cultured in stromal medium, indicating 
the loss of epithelial characteristics. This could be one of the possible reasons that explain 
why cells proliferate abnormally and form abnormal tissue in the inflamed hoof. Therefore, 
our results suggest that stopping inflammatory cell signaling, such as interleukin 2 and 6, in 
laminar progenitor cells could be a novel approach to assist normal hoof tissue generation 
after damage and providing a new perspective for future investigations. 
Finally, we illustrated how normal tissue matrix will influence K14+CD105+ 
progenitor cells. The results indicate that normal tissue matrix promotes K14+CD105+ 
progenitor cell keratinization, which displays the opposite effects of inflammatory 
interleukins culture condition mentioned above. However, future studies should include 
optimization of cell culture after sorting to minimize the culture period of K14+CD105+ 
progenitor cells. We proved that K14+CD105+ progenitor cells cultured with normal matrix 
express higher ectodermal antigen and gene expression as well as producing the organized 
fibrous matrix. In addition, we found fibrous matrix deposition on the decellularized laminar 
scaffold after loading with hoof progenitor cells isolated from other harvest conditions. This 
vital information suggests that hoof progenitor cells can survive and proliferate well after 
loading on the matrix-derived scaffold, which would contribute to a new therapeutic option 
for hoof tissue damage, such as cell-based scaffold implantation therapies designed for 
equine hoof tissue regeneration.  
As a whole, this study has summarized evidence that equine hoof multipotent 
progenitor cells play a role in either normal or abnormal hoof tissue formation, and that 
sustained abnormal EMT may be a key mechanism underlying the fibrotic pathology of 
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laminitis. Cell ultrastructure morphology and cell sorting results provide invaluable 
information for representing a way forward to the potential targeting of cell populations as a 
novel therapeutic approach for tissue healing. The inflammatory and 3D cell treatments 
developed in this study may have wide applicability for future equine progenitor research and 
in human stem cell investigations with inflammatory mediators. Further understanding of all 
the information above may allow the identification of novel therapeutic targets. All the 
outcomes in this project will contribute to future cell-based wound repair studies and 
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